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Abstract 
Multimodality imaging is an efficient, non-invasive method for investigation of molecular and 
cellular processes in vivo. However, the potential of multimodality imaging in plant studies is 
yet to be fully realized, largely due to the lack of research into suitable molecular tracers and 
instrumentation. Iodine has PET- and SPECT-compatible radioisotopes that have significant 
advantages over other radioisotopes applied in plant radioisotope imaging, and can be 
incorporated into small molecules via a variety of reactions. 
 
In this master’s thesis, a radioiodination method exploiting a novel, Dowex® H+-mediated 
addition of iodine for terminal alkynes was optimized and tested on two D-glucose analogues. 
The goal of the sugar analogue radioiodination was to develop a radioiodinated molecular 
tracer for plant carbohydrate metabolism studies. The parameters under optimization were 
activation Dowex® by HCl, reaction temperature, carrier amount, solvent, and evaporation of 
excess water. The most optimal results were achieved under the following conditions: 
Dowex® HCl-activated, reaction temperature 95 °C, amount of carrier 3.0 µmol of carrier, 
cyclohexanol as solvent, and excess water evaporated. 
 
The Dowex® approach was compared to electrophilic reactions with Chloramine T and 
Iodogen, and it was concluded that the Dowex® approach leads to superior radiochemical 
yields under the optimized conditions. The Dowex® method was successfully tested on the 
sugar analogues, resulting in a single main product at a satisfactory 50 – 56 % radiochemical 
yield. The main products were successfully characterized with NMR, and in addition the 
method was indicated to be regioselective. It is plausible that the developed method may be 
improved further in terms of radiochemical yield and molar activity, and that the method 
could prove to be a useful tool for developing novel radiodinated molecular tracers for plant 
studies. 
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Tiivistelmä 
Multimodaliteettikuvantaminen on tehokas, non-invasiivinen menetelmä solu- ja 
molekulaaristen prosessien tutkimiseen in vivo. Multimodaliteettikuvantamisen koko 
potentiaalia kasvitutkimuksessa ei kuitenkaan ole toistaiseksi voitu täysin hyödyntää, johtuen 
soveltuvien instrumenttien ja radiomerkkiaineita koskevan tutkimuksen puutteesta. Jodin 
SPECT- ja PET-yhteensopivilla radioisotoopeilla on merkittäviä etuja verrattuna aiemmin 
kasvien radioisotooppikuvantamisessa käytettyihin isotooppeihin verrattuna, ja jodia voidaan 
liittää pienmolekyyleihin useilla eri reaktioilla. 
 
Tämän pro gradu -työn tavoitteena oli optimoida uusi, Dowex® H+-välitteinen alkyynien 
radiojodiointimenetelmä ja testata menetelmää kahden D-glukoosianalogin radioleimaukseen. 
Sokerianalogien radiojodioinnin tarkoituksena oli kehittää radiomerkkiaine kasvien 
hiilihydraattimetabolian tutkimiseen. Optimoitavat parametrit olivat Dowex®-hartsin HCl-
aktivointi, reaktiolämpötila, kantajan määrä, liuotin, sekä ylimääräisen veden haihduttaminen. 
Optimaalisimmat tulokset saavutettiin seuraavissa olosuhteissa: aktivoitu Dowex®, 
reaktiolämpötila 95 °C, kantajan määrä 3.0 µmol, liuottimena sykloheksanoli, ja ylimääräinen 
vesi haihdutettu. 
 
Optimoitua Dowex®-menetelmää verrattiin elektrofiilisiin Chloramine T- ja Iodogen-
reaktioihin, ja tulosten perusteella Dowex®-menetelmä johtaa merkittävästi korkeampaan 
radiokemialliseen saantoon optimoidun menetelmän olosuhteissa. Optimoidun 
radiojodiointimenetelmän toimivuutta sokerianalogien leimaukseen testattiin onnistuneesti, ja 
päätuotteiden radiokemiallinen saanto oli 50 – 56  %. Päätuotteet karakterisoitiin 
onnistuneesti NMR:lla, ja lisäksi havaittiin merkkejä menetelmän regioselektiivisyydestä. On 
mahdollista, että kehitetyn menetelmän radiokemiallista saantoa ja molaarista aktiivisuutta 
voidaan parantaa, ja että menetelmää voidaan hyödyntää kehitettäessä uusia radiojodioituja 
merkkiaineita kasvitutkimusta varten. 
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List of abbreviations 
 
[18F]FDG = 2-Deoxy-2-[18F]fluoroglucose 
µCT =  micro (X-ray) computed tomography 
ACN =  acetonitrile 
ANOVA =  analysis of variance 
BLT =  bioluminescence tomography 
CT =  (X-ray) computed tomography 
DMF =  N,N-dimethylformamide 
DMSO =  dimethyl sulfoxide 
DOT =   diffuse optical tomography 
FMT =  fluorescence molecular tomography 
HPLC =  high-performance liquid chromatography 
MRI =  magnetic resonance imaging 
NIR =  near-infrared 
NMR =  nuclear magnetic resonance 
PET =  positron emission tomography 
RCY =  radiochemical yield 
SPECT =  single photon emission computed tomography 
TLC =  thin layer chromatography 
2 
 Introduction 
Multimodality imaging is the concept of combining two or more imaging modalities into one 
system, that is capable of scoping the target for morphological and functional information and 
compiling the acquired data into an image. Multimodality imaging is applied in a variety of 
fields, including (but not limited to) drug research, neuroimaging and oncology, and in vivo 
multimodality imaging techniques are typically applied to humans and laboratory animals; 
however, similar molecular and cellular processes, that are monitored by multimodality 
imaging in humans and animals, are also present in plants, and the potential of multimodality 
imaging in plant biology research is yet to be fully actualized. 
Molecular imaging covers a variety of imaging modalities that are applied to scope molecular 
and cellular level processes involving a molecular tracer. PET and SPECT are molecular 
imaging modalities utilizing molecular tracers labeled with radioactive isotopes, and they are 
widely used in molecular imaging due to their practically unlimited depth penetration and high 
sensitivity. The key factors to be taken into consideration when developing a molecular tracer 
for PET or SPECT studies are selecting a proper radioisotope in terms of decay mode and half-
life, the chemistry required for the radiolabeling procedure, optimization of the labeling 
conditions, and in vivo behavior of the tracer. 
The aim of this thesis was to assess the state and role of PET and SPECT multimodality imaging 
in plant studies and to optimize a radioiodination method for sugar analogues towards the end 
of utilizing these sugar analogues as molecular tracers for studying plant carbohydrate 
metabolism studies by multimodality imaging. The experimental part of the thesis utilized a 
radioiodination method for aliphatic alkynes that was first optimized using a commercially 
available precursor, and then tested on customized sugar analogues for characterization and 
assessment of radiochemical yield. 
 Molecular imaging 
 Principle of molecular imaging 
Molecular imaging is a non-invasive method to provide information of molecular dynamics in 
a living organism by localizing, characterizing and quantifying molecular and cellular processes 
involving a specific molecular probe in vivo.1–4 The molecular probe in question can be an 
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endogenous or exogenous chemical species, and in molecular imaging the spatiotemporal 
distribution of molecular and cellular processes involving the species are monitored directly or 
indirectly in two or three spatial dimensions and quantified over time, providing information of 
the kinetics and dynamics of the species.3,4  
 Imaging modalities 
Imaging modalities can be grouped by the spatial resolution, the type of energy used in 
acquisition of the information, or, most importantly, the type of acquired information. The 
energy used may be electromagnetic or mechanical, the spatial resolution ranges from 
macroscopic to microscopic, and the type of information obtained can be structural or 
functional.1,2 Different modalities also have differing penetration ranges that depend on the type 
of energy applied.  
A particular imaging modality is typically good at acquiring a certain type of information, and 
some modalities are not exclusively limited to one type of information. However, a single 
modality is often insufficient to provide both structural and functional information of a specific 
target, often due to limitations in quantitativity, sensitivity or spatial resolution.1,5 To overcome 
these limitations, different imaging modalities may be combined to provide both structural and 
functional information of a target: this is referred to as multimodality imaging. In order to 
produce a 3-dimensional image, the target may be scanned in sections and reconstructed via 
reconstruction algorithms: this is referred to as tomography.3 
Molecular imaging modalities range beyond those discussed in this review. The imaging 
methods discussed in detail are thus limited to functional molecular imaging modalities and 
structural imaging modalities typically applied in tomographic multimodality imaging together 
with nuclear imaging. Special focus is given to molecular imaging modalities involving 
radiotracers: i.e. SPECT and PET. Some common imaging modalities and their properties are 
presented in Table 1. 
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Table 1. Common imaging modalities and their properties. 
Modality SPECT PET Optical CT MRI 
Spatial 
resolution 
1 – 4 mm 
(animal)3 
5 – 12 mm 
(clinical)3 
1 – 3 mm 
(animal)3 
3 – 8 mm 
(clinical)3 
≥ 5 mm (DOT)1 
2 – 10 mm (FMT)3 
3 – 10 mm (BLT) 3 
 
50 µm (CT)5 
< 1 µm (µCT)6 
50 µm5 
Depth 
penetration1 
Not limited Not limited <10 mm Not limited Not limited 
Sensitivity 
(mol of label 
detected)5 
 10-14  10-15  10-12  10-6 10-9 – 10-6 
Type of 
energy1 
 γ-rays  γ-rays 
Visible light, 
infrared 
 X-rays 
Magnetic fields, 
radio waves 
Uses ionizing 
radiation1 
 Yes Yes No Yes No 
2.2.1. Modes of radioactive decay in molecular radioisotope imaging 
Molecular imaging modalities that are based on the detection gamma emissions (i.e. SPECT 
and PET) require that the molecular tracer applied is labelled with a radionuclide decaying via 
a suitable decay mode. For pure molecular imaging purposes (i.e. omitting theranostic 
applications) the relevant decay modes are: positron emission, which ultimately leads to two 
gamma photons emitted in opposite directions3; electron capture, which leads to a nucleus in a 
short-lived excited state that is relaxed through the emission of a single gamma photon3; and 
isomeric transition, in which a nucleus in a metastable state relaxes to ground state by emitting 
a photon3. α- and β--decaying nuclides may decay into daughter nuclides in an excited state that 
relaxes into ground state by emitting gamma photons7, and  α- and β--decaying nuclides with 
suitable gamma emissions may be utilized in theranostic applications8, but for pure molecular 
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imaging purposes these decay modes are disregarded due to the undesired damage to tissues 
their particle emissions may cause in the target. In plant studies, where damage to tissue may 
not be of as high concern as in human and animal studies, β--decaying nuclides are sometimes 
applied in real-time radioisotope imaging, but β--emissions are strongly scattered and attenuated 
in the target medium, and are mostly used to study thin systems, such as roots and leaves.9 
In β+ decay, a proton in an unstable, proton-rich nucleus is converted into a neutron, and a 
positron and a neutrino are emitted from the nucleus. One up-quark decays into a down-quark 
via the weak nuclear force, leading to a virtual W+ particle mediated emission of a positron and 
a neutrino.10 In this process the atomic number of the nucleus is reduced by one while the mass 
number remains unchanged.7 A Bohr model schematic of β+ decay is illustrated in Figure 1. 
     
Figure 1. A Bohr model schematic diagram of β+ decay. One of the protons is transformed into 
a neutron, leading to the emission of a positron and a neutrino. 
The decay energy is distributed between the positron, the neutrino, and the recoiling nuclide. 
Due to the relatively small masses of the emitted particles compared to that of the nucleus, the 
recoil energy is negligibly small, and the total decay energy is thus considered to be distributed 
solely between the positron and the neutrino.7 Energy values for the emitted particles are not 
constant and can be presented as a continuous probability distribution spectrum, the beta 
spectrum.7,11 The emitted positron loses its kinetic energy gradually while travelling through a 
medium, until the energy is low enough to allow interactions with an electron.7 Positron-
electron interaction leads to an annihilation event, in which both particles are converted into 
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two photons.11 Since the kinetic energy of both interacting particles in positron-electron 
annihilation is relatively low and therefore negligible when calculating the energy of the emitted 
photons, the total energy of the emitted photons is equal to the rest mass of an electron and a 
positron: this leads to two 0.511 keV gamma photons being emitted in opposite directions.11 A 
schematic of electron-positron annihilation is illustrated in Figure 2. 
 
Figure 2. A schematic of electron-positron annihilation. Interaction of the particle-antiparticle 
pair leads to both particles being annihilated and converted into electromagnetic energy in the 
form of two 0.511 keV gamma photons emitted in opposite directions. 
Electron capture is a competing process for β+ decay, and in this process an unstable, proton-
rich nucleus absorbs an electron from its inner electron shells, transforming the proton into a 
neutron and causing the emission of a neutrino that carries all of the decay energy.7 In this 
process the atomic number is reduced by one while the mass number remains unchanged. A 
Bohr model schematic of electron capture is illustrated in Figure 3. 
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Figure 3. A Bohr model schematic of electron capture. A proton captures an electron from the 
inner shell, transforming into a neutron and resulting in a daughter nuclide in an excited state. 
The excited state relaxes into ground state, with the excitation energy emitted as a gamma 
photon. The inner-shell vacancy is filled by an electron from an outer shell, leading to X-ray 
emissions. 
Electron capture may lead to a daughter nuclide in an excited state, whose transition to ground 
state produces gamma emissions.3,7 The vacancy in the inner shell is filled by an electron from 
an outer shell, producing X-ray emissions.3 The energy released in filling the vacancy may also 
be transferred to an orbital electron, which leads to the electron being ejected: this process is 
called Auger effect.3  
Isomeric transition is the relaxation of a nucleus in a particularly long-lived, metastable excited 
state, that proceeds through gamma emissions.3 An excited nucleus, metastable or otherwise, 
may also relax through a process called internal conversion, in which the excitation energy of 
the nucleus transfers to an orbital electron, leading to the electron being ejected with high 
energy.7 
2.2.2. Functional imaging 
The purpose of functional imaging is the localization, characterization and quantification of 
processes in the target system. In the context of this work, molecular imaging is considered a 
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subtype of functional imaging, and the terms overlap to some extent. The distinction between 
functional and molecular imaging is essentially in the scale and type of the processes under 
observation. In functional imaging the entity under study may be a process that is not of 
molecular or cellular nature, such as myocardial blood flow.12 Molecular imaging, however, 
involves a molecular probe whose in vivo kinetics and dynamics are the processes under study, 
and the scale of the processes are on a fine, molecular or cellular level.4 
2.2.2.1. Single photon emission computed tomography 
Single photon emission computed tomography (SPECT) is an imaging modality that utilizes 
molecular tracers labeled with gamma-emitting radionuclides.1 The radiotracer is introduced to 
the subject typically by an intravenous injection, and the distribution of the tracer is determined 
by detecting the gamma emissions with a gamma camera.1 The gamma emission occurs when 
a decay event of an unstable nuclide leads to a daughter nuclide in an excited state.7,11 The 
excess energy of this state is released as high energy electromagnetic radiation when the nuclide 
relaxes to ground state.7 By scanning the target from multiple angles in transversal slices, a 3-
dimensional image illustrating the distribution of the molecular tracer is then reconstructed.1 
A SPECT system consist of a gamma camera that detects the incident gamma photons and 
converts the energy into an electric pulse, and a computer that reconstructs the image.3,13 The 
gamma camera itself consists of three main components: a parallel- or a pinhole collimator, a 
scintillation crystal, and photomultiplier tubes.13,14 The collimator filters the incident photons 
so that only those photons that are emitted perpendicular to the camera plane are recorded.14,15 
This improves image quality by filtering gammas scattered outside the target from interacting 
with the scintillation crystal: however, this reduces the sensitivity of a SPECT scan, since some 
emissions from inside the target are also filtered.15 The photons that pass the collimator interact 
with the scintillation crystal (typically a NaI(Tl) crystal), producing a flash of electromagnetic 
radiation in the visible light spectrum that is transformed into an electric pulse and amplified in 
the photomultiplier tube.13 These pulses are then counted and recorded by a computer that 
reconstructs a two-dimensional image of the distribution and density of detected decay 
events.3,15 A schematic of a SPECT system is illustrated in Figure 4. 
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Figure 4. Schematic of a SPECT system. Emissions perpendicular to the camera plane pass the 
collimator and are detected, while other gammas are scattered and not detected. 
A 3-dimensional image of the distribution of the radiolabeled tracer is reconstructed by rotating 
the camera around the target in a transversal plane, acquiring two-dimensional images of the 
target from multiple angles and processing the data with computer algorithms.3,16 An illustration 
of SPECT image acquisition is presented in Figure 5. 
10 
 
Figure 5. An illustration of SPECT image acquisition. The pictures on top row depict a SPECT 
camera imaging the target from two angles, and the bottom row pictures depict the planar 
images acquired from each angle. The red areas are concentrations of radioactivity. 
The planar images are compiled into a sinogram, which is a container for the projection data 
for reconstructing the images.1,3 The sinogram is then processed with a reconstruction algorithm 
to reconstruct an  image of radioactivity distribution in the target.3 The reconstructed, 
transversal tomographic slices are then stacked on top of each other to reconstruct a whole-
target image. An illustration of SPECT image reconstruction is presented in Figure 6. 
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Figure 6. An illustration of SPECT image reconstruction. The top row depicts a top-down 
sinogram of a tomographic slice, with the directions of image acquisition visualized. The center 
row depicts sinograms in three dimensions, and the bottom row is a complete, processed and 
reconstructed image 
The gamma photon is emitted directly from the position of the decay event: therefore, a SPECT 
scan’s spatial resolution is not limited by photon energy.1 However, the collimator used to filter 
out scattered gamma photons also filters emissions originating from inside the target, degrading 
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sensitivity.13 Reduction of collimation or an un-collimated system may be used for studies 
where sensitivity is favored over spatial resolution.13,17 A SPECT scan may be executed with 
two (or more) different molecular tracers labelled with different radionuclides whose gamma 
emission energies are suitably far apart, so that a detector with sufficient energy resolution can 
differentiate the gamma emissions by energy.3 
2.2.2.2. Positron emission tomography 
Positron emission tomography (PET) is an imaging modality that utilizes a radiotracer labelled 
with a positron-emitting radionuclide. The tracer is injected to the subject, and the location of 
the radioisotope is determined by detecting the two gamma photons resulting from the 
annihilation event following the positron emission.15 The positron emitted travels through the 
medium, losing its kinetic energy until the energy is low enough to permit interactions with an 
electron.7,13 The positron and electron, being a particle-antiparticle pair, annihilate upon 
interaction, leading to the conversion of the masses of the particles into electromagnetic 
radiation.7  
The gamma photons emitted in opposite directions from the location of the annihilation event 
are detected by a dual-head gamma camera or a toroidal scintillation detector.16 The target is 
scanned in transversal slices, which are then reconstructed to an image displaying the locations 
of detected annihilation events, providing information of the distribution of the molecular tracer 
inside the target.3 The tomographic slices are then stacked to reconstruct a 3-dimensional 
whole-target image. A schematic of a PET system is illustrated in Figure 7. 
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Figure 7. Schematic of a PET system with a toroidal detector. The annihilation gammas emitted 
in opposite directions reach the detector array simultaneously and are detected in coincidence. 
The distance traveled by the positron before annihilation is determined by the initial kinetic 
energy of the positron.3 This sets the limits to the spatial resolution of the PET scan: the longer 
the mean positron range, the lower the resolution.13 Unlike a typical SPECT gamma camera, a 
PET detector does not utilize a collimator to filter scattered gamma photons; instead, the 
detector uses coincidence detection to distinguish the annihilation gammas from other gamma 
emissions interfering with the measurement, meaning only the events that are detected within 
a sufficiently short time interval are recorded.13,16 
2.2.2.3. Optical tomography 
Optical tomography covers a variety of techniques that exploit the properties of visible light 
and near-infrared radiation (NIR) to acquire information that can be of structural or functional 
nature, depending on the technique applied. Optical tomography is based on the variations in 
light-scattering and –absorbing properties of different materials, and due to the non-penetrating 
nature of visible light, the target material is usually light-transmitting or translucent, such as 
soft tissues. The acquired information is then processed to produce a three-dimensional image 
of the target. Optical tomography has the benefit of not relying on ionizing radiation or 
expensive equipment1. However, visible light and NIR lack the penetration of more energetic 
electromagnetic radiation, which sets limitations to the applications of optical imaging 
modalities.1 Optical tomography, and optical imaging techniques in general, range beyond the 
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techniques described in this chapter, and the techniques described below were selected as points 
of interest due to being applied in multimodality imaging, as well as being established imaging 
modalities in plant studies. 
Diffuse optical tomography (DOT) is a technique applying near-infrared (700 – 900 nm) 
spectroscopy to scope the target.18 When NIR radiation is projected on the target, a small 
quantity of the incident photons will travel in the target medium nearly unscattered, along the 
axis of the incident light.19 These photons can be differentiated from the scattered light and 
detected separately. The target is scoped to detect differences and changes in absorption and 
scattering properties in the target medium, and the acquired information is processed to obtain 
an image of the target.18 An example of application of DOT is determining the spatial 
distribution of oxy- and deoxyhemoglobin in brain19. 
Fluorescence molecular tomography (FMT) is a technique using molecular probes based on a 
fluorescent compound, a fluorochrome, whose position in the target can be located by exciting 
the fluorochrome with a laser pulse and detecting the fluorescence emissions following the 
excitation.20,21 Fluorochromes can absorb an incident photon of an appropriate wavelength and 
transition to an excited electronic energy state, which is unstable and will soon decay into a 
ground state. The excess energy from the transition to the ground state is emitted as a photon, 
and due to some of the deposited energy being spent on transitions between vibrational states, 
the emitted photon is of lower energy than the one absorbed.20 The emitted photons can thus be 
differentiated from incident photons by a difference in wavelength, and the location of the probe 
is determined by detecting the emissions.20,21 A three-dimensional image can be reconstructed 
by scanning the target in slices, and distribution of the fluorescent probe can be quantified over 
time. 
Bioluminescence tomography (BLT) utilizes the properties of luciferases, enzymes capable of 
catalyzing an oxidative process on its substrates, small molecules referred to as luciferins, that 
exhibit emission maxima at 480 – 635 nm.22,23 Luciferases are generally of biological origin 
(e.g. isolated from Photinys pyralis fireflies) and require the presence of cofactors such ad 
molecular oxygen, Mg2+ and ATP to induce bioluminescence.23 After a luciferase has acted on 
its substrate, the oxidized product is in an excited state, and electromagnetic radiation in the 
visible light spectrum is emitted when the oxidation product relaxes to ground state: these 
emissions can then be localized and quantified to study the molecular and cellular processes 
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involved.24 BLT does not require an external light source to induce bioluminescence, and the 
emissions can therefore be detected with ultra-sensitive equipment under low-light 
conditions.21,23 
2.2.3. Structural imaging 
Structural imaging is the imaging of a target at a certain point of time, providing a static image 
that can be used to study and analyze the morphology of the target. In the context of 
multimodality imaging, structural information is used in conjunction with functional 
information for localizing the concentrations of the molecular probe in the target.25 The 
structural image also serves as a photon attenuation map for quantification of gamma emissions 
from within the target.25–27 
2.2.3.1. Computed tomography 
Computed tomography (CT) utilizes X-rays to scope differences in attenuation coefficients of 
the target to obtain three-dimensional structural information. The target is scanned with a 
monoenergetic X-ray source from multiple angles to determine the attenuation of the incident 
radiation in the target and to reconstruct a cross-sectional image illustrating the distribution of 
X-ray attenuation in two dimensions15. These images are then stacked to reconstruct a three-
dimensional structural image of the target.  
CT has practically unlimited depth penetration, a short acquisition time (minutes), and a high 
spatial resolution which can be further enhanced with contrast agents.1,15 CT may be applied in 
some functional imaging purposes, such as perfusion and ventilation imaging1,28, but the 
sensitivity of CT is often insufficient for molecular imaging purposes: hence, most applications 
of CT concern acquiring structural information.1,15 
X-ray microtomography (µCT) is an imaging technique characterized by a spatial resolution 
better than 1 µm, and it can be used to acquire very high-resolution structural information.1,6,29 
A µCT system is designed for smaller field of view and higher resolution than a regular, clinical 
CT system, but is built on the same physical principles, and can be combined with other imaging 
modalities.1 µCT is an imaging modality applied in a wide variety of fields: it can be used to 
scope mineralized and soft tissues1,30, and materials such as wood, cement and composite 
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materials6,29. The native soft tissue contrast of µCT is relatively low, but can be enhanced with 
contrasting agents, such as iodine and phosphotungstic acid.30,31 
2.2.3.2. Magnetic resonance imaging 
Magnetic resonance imaging (MRI) is an imaging modality that utilizes the phenomenon of 
nuclear magnetic resonance (NMR). Nuclei with an odd number of nucleons have non-zero 
spin, and thus have an associated non-zero magnetic dipole momentum derived from a non-
zero nuclear angular momentum.15,32 When exposed to an external, constant magnetic field, 
magnetic nuclei can align parallel or anti-parallel to the applied magnetic field, and in thermal 
equilibrium more nuclei align with the field than against it, resulting in a net macroscopic 
magnetization vector aligned parallel to the field.15,32 The nuclear angular momentum causes 
the nuclear magnets to precess around the magnetic field: the direction of precession is 
dependent on the orientation of the nuclear magnet about the axis of the applied magnetic field, 
and the frequency of precession is dependent on the magnitude of the magnetic field and the 
gyromagnetic radius of the nucleus.32 The angular frequency of precession in a magnetic field 
of a specific strength is called the Larmor frequency. A non-equilibrium state may be generated 
by exciting the spin system with a oscillating radiofrequency pulse whose frequency matches 
that of the Larmor frequency, causing the spins to absorb the energy of the pulse and flip 
between energy states.15 This changes the direction of the net magnetization vector, causing it 
to fall out of alignment with the applied magnetic field. Following the excitation, the nucleus 
relaxes by precessing at the nucleus’s Larmor frequency about the applied magnetic field axis, 
generating an oscillating magnetic field that can be detected due to inducing a voltage in a 
detection coil.32 
99,98% of hydrogen is of the isotope 1H, which has a non-zero nuclear spin. Due to its 
ubiquitousness and presence in many molecules, e.g. water and fatty acids, 1H is the most 
essential isotope in MRI, and typically MRI is applied to scan for distribution and concentration 
of water to scope the structure of a water-containing target.1,32 
MRI can be used in a tomographic fashion, scanning the target in slices to reconstruct a three-
dimensional image of the target. The Larmor frequency and the phase of precession can be 
manipulated by variations in the strength of the applied magnetic field: thus, a signal can be 
localized in the acquisition plane by creating a gradient in the applied magnetic field so that the 
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strength of the field varies with a linear relationship to distance.32 The location of the signal is 
then determined in one direction by variations in the exciting frequency, and in an orthogonal 
direction by phase changes in the detected signal.32 
 Multimodality imaging 
A single molecular imaging modality is often insufficient to acquire all the essential information 
from a target.1,5 Multimodality imaging is the combination of two or more different molecular 
imaging modalities to acquire both structural and functional information of the target; either 
sequentially as independent systems; or simultaneously, integrating the modalities into one 
system.5,33 The most established multimodality imaging combinations are SPECT/CT and 
PET/CT, but MRI has gained favor over CT due to having superior sensitivity and not relying 
on use of ionizing radiation.33–35 Combination of optical modalities with PET to overcome the 
limitations in each modality (penetration depth and spatial resolution, respectively) has been 
reported.5,33 Basically any arbitrary combination of imaging modalities is possible, assuming it 
is capable of yielding the needed information.33 
2.3.1. Applications of multimodality imaging 
Multimodality imaging is a way to non-invasively study the in vivo behavior of a molecular 
probe in real time over a structural framework, and its applications typically concern studies of 
molecular and cellular processes in living subjects, both humans and experimental 
animals.1,33,36,37 Multimodality imaging is particularly suitable for applications in which high 
resolution and sensitivity are required, and in which the studied processes need to be localized 
in real-time and quantified over time. Multimodality imaging is widely used to facilitate drug 
research and monitor human health: for example, studying pharmacokinetics and -dynamics of 
a drug candidate using sub-threshold doses and imaging of brain structure and function are 
typical applications of multimodality imaging.1,3,37,38 Perhaps the most well-known example of 
a multimodality imaging application are multimodal [18F]- fluorodeoxyglucose studies that are 
conducted to quantify the distribution and accumulation of 18F-labeled glucose inside the target 
biological system and combine this functional information with a morphological image of the 
target.33,39 This image can then be used to locate sites of abnormal glucose metabolism, such 
cancerous tissues, infection and inflammation, and osteoarthritis.3,33,37,40  
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2.3.2. Radioisotope and multimodality imaging in plants 
While multimodality imaging techniques are widely applied in studies involving humans and 
animals, their utilization in plant studies appears to be less common.9,41–43 Current molecular 
and cellular level imaging techniques used in plant studies mostly utilize autoradiography and 
optical imaging modalities, out of which fluorescence imaging is the most prevalent.9,44–49 The 
applications of molecular imaging in plants include, but are not limited to, phenotyping and 
studying of autophagy, nutrient transport and chloroplast movement.9,46,47,49,50  
Autoradiography methods require termination of physiological activity in the target and 
produce only static images of radiotracer distribution, and are therefore incompatible in real-
time imaging approaches.9,51 In addition, autoradiography can be applied only in 2-dimensional 
imaging of planar systems, such as leaves, and is ill-suited for 3-dimensional imaging of whole 
plants.51 Optical imaging modalities can be used to study molecular and cellular processes of 
plants in real-time and may be combined with a structural imaging modality to study the target 
in a multimodality fashion, but the limited penetration depth hinder the applicability of optical 
imaging to monitoring processes occurring on the surface or in the thinner parts, such as leaves, 
of the plant. Furthermore, fluorescence imaging modalities require darkness for detection while 
plants require light for normal physiological activity, rendering application of real-time 
fluorescence imaging to plants complicated.41 
Majority of the documented real-time radioisotope imaging systems for plants are based on β-- 
and β+-emissions9,41,43,51–55. Gamma camera has been used to study 137C uptake56, and at least 
one un-collimated detector single-photon system for small animal and plant imaging has been 
presented17. The combination of PET and MRI has been used to investigate structures, transport 
routes and translocation dynamics using 11C-labelled tracers and [11C]CO2
52, and a PET/CT 
system has been utilized in [18F]FDG- and [68Ga]gallium citrate translocation studies57. MRI 
and CT as independent imaging modalities are relatively well established structural imaging 
modalities in plant studies58–62, so the basis for further development of plant multimodality 
imaging systems exists. µCT, in particular, has proved to be an effective imaging modality in 
plant studies due to its high resolution29: for example, it has been used to study the accumulation 
and distribution of selenium in Arabidopsis thaliana roots63, and changes in tissue density of 
lyophilized Brassica oleracea leaves.64 
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The most significant issue in imaging systems utilizing β--emissions is the self-absorption of β-
-particles in the target, which limits the usefulness of these systems to imaging only thin targets, 
such as roots and leaves.9 In addition to self-absorption in the target, attenuation of β--emissions 
may occur in the airspace between the target and the detector.65 β+-emissions travel in the 
medium until their kinetic energy is low enough to allow annihilation: therefore, when imaging 
thin targets, positron escape may occur particularly with high-energy β+-emissions.9,66  
Radioisotopes used in plant radioisotope imaging include (but are not limited to) 11C, 13N, 18F, 
15O, 32P, 35S, 45Ca, 55Fe, 137Cs and 68Ga, and among their fields of application are nutrient 
uptake, water movement and CO2 translocation studies, in which the radionuclides are bound 
to simple, neutral molecules such as H2O or CO2, or in mono-and polyatomic cations and anions 
such as Cs+ and (PO4)
3-.41,56,57,67 With the exception of [18F]FDG studies51,57,68, more complex 
small molecules appear to be rarely used in plant radioisotope imaging: therefore, novel 
molecular tracers could open new possibilities in developing and utilizing multimodality 
imaging methods for plant studies. Carbon, nitrogen and oxygen are ubiquitous in organic 
compounds and may be substituted with 11C, 13N and 15O: however, the half-life of these 
radionuclides (t½ = 20.4, 9.96 and 2.03 min, respectively) limits their applicability to 
experiments of a short timescale.57,67 In addition, their applicability is further limited by their 
decay mode of positron emission, which may result in positron escape when probing thin 
systems; this is also true for 18F. However, applying PET in real-time, non-invasive plant 
imaging is becoming more common, and PET/CT and PET/MRI systems for plant imaging 
have been reported52,57; thus, further utilization of multimodality imaging systems involving 
PET in plant studies depends on the development novel molecular tracers, particularly small 
molecules labelled with long-living positron-emitting isotopes such as 124I, 89Zr and 86Y (t½ = 
100.2, 78.4 and 14.7 h, respectively)69, so that compounds with slower kinetics may be utilized.  
PET appears to be a more commonly applied tomographic radioisotope imaging modality in 
plant studies than SPECT, and radionuclides with SPECT-compatible gamma emissions are 
rarely exploited in plant radioisotope imaging. A study in which 137Cs uptake was imaged using 
a gamma camera is reported56, and an un-collimated detector single-photon imaging system 
was used in a 99mTcO4
- xylem transport study17; however, in these studies the gamma camera 
was used in planar imaging, not in a tomographic fashion, and a true SPECT system for plant 
studies is yet to be reported. In the aforementioned studies the gamma-emitting nuclides were 
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applied in the form as cations or anions, and studies, in which the radionuclide was introduced 
in the target system in the form of a neutral molecule, are yet to be reported. The functionality 
of a SPECT imaging system is not hindered by positron escape, and therefore SPECT could 
prove to be a superior imaging modality particularly when imaging thin parts of a plant. 
However, to fully exploit these advantages, further research is needed in combining and 
applying SPECT with MRI or CT in plant studies, and in developing novel, SPECT-compatible 
molecular tracers. 
Radioisotope imaging modalities are superior in terms of sensitivity and penetration depth to 
optical imaging modalities, and maintaining conditions required for natural physiological 
activity in the target plant are less complicated when using real-time radioisotope imaging 
methods, since these methods do not require darkness (as do optical imaging modalities) nor 
termination of physiological activity (as does autoradiography). The obvious advantage PET 
and SPECT imaging modalities have over planar radioisotope imaging is the capability of 
providing 3-dimensional, functional information of the target57, and, when combined to a 
structural imaging modality in a multimodality fashion, could prove to be a powerful tool in 
plant studies, particularly when imaging thick systems and kinetics of organic biomolecules in 
plants. However, PET and SPECT have yet to become established imaging modalities in plant 
studies, and more research in developing suitable instrumentation and molecular tracers is 
required to fully realize the potential of PET or SPECT multimodality imaging of plants. 
 Iodine in multimodality imaging 
 Properties and chemistry of iodine 
Iodine is an element of the halogen group with atomic number 53.70 At standard conditions 
molecular iodine, I2, is present as a lustrous dark-gray, non-metallic solid that sublimates into 
a violet gas.3,70,71 I2 is only slightly soluble in water, but dissolves readily in nonpolar solvents.
3 
Iodine occurs in oxidation states −1, +1, +3, +4, +5, +6 and +7, oxidation states +3, +4 and +6 
being relatively uncommon.70 Physical properties of iodine are presented in Table 2. 
Table 2. Physical properties of iodine. 
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Atomic 
number3 
Atomic 
radius (pm)3 
Ionic (I-) 
radius (pm)3 
Electron 
structure3 
Electronega
tivity 
(Pauling 
scale)3 
Oxidation 
state (most 
common in 
bold)3 
Ionization 
potential 
(eV)72 
53 133 216 [Kr]4d105s2
5p5 
2.66 −1, +1, +3, 
+4, +5, +6, 
+7 
10.44 (1st) 
19.13 (2nd) 
32.96 (3rd) 
In comparison to other stable halogens (astatine is a halogen with no known stable isotopes; its 
properties are not well known and is thus omitted in the following comparisons), iodine is less 
electronegative and larger in ionic radius. These properties render iodine’s electron cloud 
relatively polarizable, and as a consequence molecular iodine is considered formally to have 
the structure of I+ ̶ I- in aqueous solutions.3 The electronegativity and ionic radius of iodine are 
comparable to those of a methyl group, and when assessing molecular interactions with species 
containing iodine atoms, its properties can be approximated to be close to those of a methyl 
group.73 Van der Waals radius and electronegativity for stable halogens and methyl group are 
presented in Table 3. 
Table 3. Van der Waals radius and electronegativity for stable halogens and the methyl group.73 
 H F Cl Br I CH3 
Van der 
Waals 
radius (Å) 
1.20 1.35 1.80 1.95 2.15 2.00 
Electronega
tivity 
2.28 3.95 3.03 2.80 2.47 2.30 
Due to the relatively low electronegativity of iodine, bond enthalpies of diatomic halogen 
molecules, hydrogen halide and carbon–halogen bonds are lower for iodine than for other stable 
halogens.71,72 The length of carbon–iodine bonds decreases with increasing s character of the 
carbon, while bond enthalpy increases, implying a correlation between bond stability and 
degree of s character.73 Bond lengths of C–I bonds are presented in Table 4. 
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Table 4. Lengths of C-I bonds.73 
s character of carbon sp3 sp2 (ethylenic) sp2 (aromatic) sp 
Bond length (Å) 2.13 2.09 2.05 1.99 
The electrophilic iodine species I+ readily complexes with nucleophiles, and therefore does not 
exist as a free species in aqueous solutions.3 Electrophilic iodine reacts with oxygen forming 
neutral oxides, most of which are unstable and thus unisolatable, and reactions with water lead 
to a multitude of anionic species, the most stable iodine anions being iodide, iodate and 
periodate. In nature iodine occurs mostly in oxidation state -1 in the form of sodium or 
potassium salts.3 Anions and oxides of iodine in common oxidation states are presented in Table 
5. 
Table 5. Anions and oxides of iodine in common iodine oxidation states.70 
Oxidation state -1 +1 +5 +7 
Anion name iodide hypoiodite iodate periodate 
Anion formula I- IO- IO3- IO4- (metaperiodate), 
IO65- (orthoperiodate) 
Oxide name - diiodine monoxide diiodine pentoxide,  
diiodine tetroxide,  
tetraiodine nonaoxide 
tetraiodine noanoxide 
Oxide structure - I2O O(IO2)2 (pentoxide), 
(IO2)2 (tetroxide), 
I(OIO2)3 (nonoxide) 
I(OIO2)3 
 Stable iodine as a contrasting agent in CT 
The native soft-tissue contrast of CT and µCT is relatively low, but can be improved with the 
use of a suitable contrasting agent. Iodine-based contrasting agents are common in CT studies,  
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(particularly in µCT) due to iodine’s X-ray attenuating properties74, and one of the more popular 
methods of enhancing CT contrast in ex vivo and in vitro studies is staining with Lugol’s iodine, 
an aqueous solution of  two parts of KI to one part of I2.
75 However, for in vivo purposes such 
as cardiac, vascular and cancer imaging, more attractive choices for contrasting agents are 
iodinated small molecules and iodine-containing nanoparticles.74,76 Iodine-containing 
nanoparticles are particularly attractive for in vivo studies, since their renal clearance rate is 
typically slower than that of iodinated small molecules, enabling imaging over extended time 
periods74,76. Another attractive feature of iodine as a CT contrasting agent is the possibility of 
simultaneously using a radioiodinated tracer and an iodinated contrast agent in PET/CT and 
SPECT/CT multimodality imaging, since the improved CT resolution can be exploited to 
improve the quality of attenuation correction of the radioisotope imaging modality, and thus 
improve SPECT or PET image quality.76 
 Radioisotopes of iodine in molecular imaging 
Iodine has 37 known isotopes, of which only 127I is stable: the rest undergo radioactive decay.73 
The longest-lived radioisotope of iodine is 129I, with a half-life of 1.57 x 107 y.7 129I is generated 
in the atmosphere by cosmic radiation-induced nuclear reactions, and it is the only radioisotope 
of iodine naturally present in the environment, although only in trace amounts.7 The rest of the 
radioisotopes of iodine have half-lives of less than 60 days and are all synthetic, being either 
fission products or produced with charged particle reactions and neutron activation.  
There are many different modes through which an unstable nucleus may decay, but in the 
context of SPECT and PET imaging only the decay modes which lead to sufficiently abundant 
emissions of gamma photons of a suitable energy are useful. The daughter nuclide is ideally 
stable, since additional gamma emissions from subsequent decay events may interfere with the 
measurement. The gamma energy must be sufficiently high to penetrate target medium; 
however, the higher the gamma energy, the less likely it is to interact with the detector, leading 
to compromised sensitivity. In addition, high energy gamma emissions cause issues concerning 
radiation safety due to their penetrating nature, and thick lead shielding must be used to avoid 
external exposure. The half-life of the nuclide is an important aspect considering in vivo 
applications. A suitable (radiological) half-life depends on the kinetics that determine the 
biological half-life of the compound: the nuclide must be long-lived enough to assure the 
radiolabeled compound reaches its destination, but a long half-life leads to less decay events 
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during the measurement period, compromising sensitivity, in addition to needlessly increasing 
patient dose in medical applications.77,78 
In the context of this study, four radioisotopes of iodine are discussed as radiopharmaceutically 
relevant and suitable for molecular imaging purposes due to their decay properties. These 
isotopes and their most significant decay properties are presented in Table 6. 
Table 6. Radiopharmaceutically relevant radioiodine isotopes and their decay properties.73 
Isotope t½ Decay mode(s) E (MeV) 
123I 13.22 h EC (100 %) γ 0.159 (83.3 %) 
124I 4.176 d 
β+ (22.4 %)  Eβ+max 2.13 (10.8 %) 
EC (77.6 %) 
γ 0.603 (62.9 %)  
0.723 (10,4 %)  
1.691 (11.2 %) 
125I 59.41 d EC (100 %) γ 0.0355 (6.68 %) 
131I 8.021 d β- (100 %) 
Eβ-max 0.606 (89.9 %) 
γ 0.284 (6.14 %)  
0.365 (81.7 %) 
0.637 (7.17 %) 
123I is a short-lived isotope of iodine that decays to 123Te (t½ = 1.3 x 1013 y; observationally 
stable) via electron capture, emitting abundant (83 %) 159 KeV gamma emissions.73,79 123I is 
applied in SPECT imaging due to its ideal gamma energy, and its half-life is sufficiently long 
for studying pharmacokinetics over extended periods.78–80 Using 124Xe as target material, 123I 
can be produced in a cyclotron via several nuclear reactions, e.g.:79  
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124Xe (p, 2p) 123I 
124Xe (p, pn) 123Xe (t½=2.08 h) → 123I 
124Xe (p, 2n) 123Cs (t½=5.9 min) → 123Xe (t½=2.08 h) → 123I 
124I is an isotope of iodine with a moderate half-life. 124I decays to stable 124Te via positron 
emission and electron capture, and it is applied in PET imaging.73,80,81 Due to its half-life, 124I 
is particularly suitable for labelling molecular tracers that have particularly slow 
pharmacokinetics.73,80 It can be produced in a cyclotron via the reaction:73,80  
124Te (p, n) 124I 
125I is a long-lived isotope of iodine that decays to stable 125Te via electron capture. Its gamma 
emissions are relatively weak compared to other radiopharmaceutically relevant iodine 
isotopes, rendering 125I incompatible with in vivo SPECT imaging. The most significant gamma 
emission is not particularly abundant (6.68 %), and due to their low energy, 35.5 keV, the 
emissions are significantly attenuated in the target and thus hard to detect outside the target.82 
However, the relatively long half-life and easily attenuated gamma emissions render 125I 
particularly suitable for in vitro studies due to the relative ease of handling and protective 
measures.73,82 125I also produces abundant Auger electrons, and it is used in sealed-source 
brachytherapy for treatment of cancer of the eye, prostate, breast, etc.73,83,84 125I can be produced 
in nuclear reactors via the reaction: 
124Xe (n, γ) 125Xe (t½=17 h) →125I 
131I has a moderate half-life, and decays to 131Xe via β- decay. Due to its decay mode it is not 
used for pure imaging purposes; 131I is rather used in radiotherapy while its gamma emissions 
can be utilized simultaneously in imaging, rendering 131I suitable for theranostic applications. 
131I is produced in nuclear reactors as a fission product of 235U: 
235U (n, fission) 131I, 99Mo, 117Pd, 137Cs, … 
 Radiolabeling methods with radioiodine 
There are numerous known iodination reactions, all of which can generally be used in 
radioiodinations. However, radiochemical synthesis has its own special conditions to be 
considered, and usually a known iodination method needs to be specifically adapted to 
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radiochemical purposes to overcome these conditions. Most radiopharmaceutically relevant 
isotopes of iodine have characteristically short half-lives: therefore, the radioiodination reaction 
has to be optimizable for relatively short (e.g. < 1 h) reaction times in order to avoid excess 
product loss due to radioactive decay, and ideally the labeling procedure can be executed in one 
step and one pot.73 When the concentration of radioiodine in a radioiodination reaction is low, 
stable iodine may need to be added to the reaction mixture as isotopic carrier to ensure that the 
radionuclide behaves normally during the reaction.85 
Iodine is a volatile element, and safety precautions include prevention internal exposure via 
inhalation of radioiodine when working with radioactive iodine isotopes. In addition, proper 
lead shielding is required to prevent external exposure to radiation. In practice this means that 
radioiodinations should be carried out in a ventilated environment, such as a glove box or a 
fume hood, and that, during working with radioiodine and handling radioiodinated samples, 
external exposure to radiation should be prevented by sufficiently thick lead shielding and 
avoiding positioning oneself unnecessary close to the source of radiation. When working with 
125I, additional care must be taken to prevent contaminating detectors etc., since 125I:s long half-
life renders these contaminations particularly troublesome. 
Most essential radioiodination reactions are nucleophilic and electrophilic substitutions, and 
these reactions are discussed in detail in the scope of this study. In addition, halogenations of 
alkenes and alkynes are discussed separately. 
3.4.1. Nucleophilic substitution 
In nucleophilic substitution the attacking species acts as the nucleophile, donating an electron 
pair to a covalent bond formed with an electrophilic species, while the electrophile’s bond with 
the leaving group, the nucleofuge, is disconnected, and the nucleofuge leaves with an electron 
pair.73,86 In the context of nucleophilic radioiodinations, the attacking species is the iodide 
anion, I-, which can exist as a free species and is thus easy to introduce into the reaction mixture 
in the form of, for example, NaI. Nucleophilic substitutions may occur in aliphatic and aromatic 
compounds, and the mechanisms vary depending on the aromaticity, or lack thereof, of the 
substrate.73,86 
Nucleophilic substitution in aliphatic compounds occurs mostly via SN1 and SN2 mechanisms. 
The essential difference between SN1 and SN2 mechanisms is at which step the leaving group 
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is disconnected from the compound: in SN1 the disconnection occurs before the nucleophile 
forms a bond with the electrophile, whereas in SN2 mechanism the nucleophile first attacks the 
electrophile, forming a transition state with a -1 net charge and in which the negative charge is 
distributed between the nucleophile and the nucleofuge, after which the leaving group is 
disconnected.73,86 These differences are demonstrated in Equation 1 and Equation 2: 
𝑆𝑁1: 𝑅𝑋 + 𝑁𝑢
− ⇌ 𝑅+ + 𝑋− + 𝑁𝑢− ⇌ 𝑅𝑁𝑢 + 𝑋− 
Equation 1 
𝑆𝑁2: 𝑅𝑋 + 𝑁𝑢
− ⇌ [𝑋𝛿
−
− 𝑅 − 𝑁𝑢𝛿
−
]
−
⇌ 𝑅𝑁𝑢 + 𝑋− 
Equation 2 
where R is the substrate, X (≠ H) the leaving group and Nu the nucleophile. Another distinctive 
feature between SN1 and SN2 mechanisms is the effect on stereochemistry: SN2 results in the 
reversal of stereochemistry, whereas in SN1 the nucleophile may attack from both sides, leading 
to a racemic mixture of products.86 This is demonstrated in Figure 8 
 
Figure 8. Schematics of SN1 and SN2 mechanisms. In SN1 reaction a racemic mixture is 
produced, whereas in SN2 the stereochemistry is reversed. 
In SN1 the rate-determining step is the unimolecular step in which the leaving group is 
disconnected: therefore, the reaction rate displays first-order dependence on electrophile 
concentration.86 In SN2 the rate-determining step is the bimolecular step in which the transition 
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state is formed: the formation of the transition state displays first-order dependence on the 
concentrations of the nucleophile and the electrophile, meaning the overall reaction rate follows 
second-order kinetics.86  
The solvent has a significant effect on the reaction rate of SN1 and SN2 reactions. The reaction 
rate depends on solvation of the transition state, reagents and products, and SN1 reactions favor 
protic solvents, whereas SN2 reactions favor aprotic solvents.
86 The polarity of the solvent also 
affects the reaction rate, depending on the mechanism: SN1 reaction rates increase with the 
polarity of the solvent, whereas for SN2 reactions favor less polar (but polar nonetheless) 
solvents.73,86 
The leaving groups in aliphatic substitutions are typically sulphonates, such as triflates, 
mesylates and tosylates, or halides.73,86 In aliphatic iodinations, sulphonates are generally 
considered to be better leaving groups than halides; however, due to practical reasons  a halide 
is often selected as the leaving group.73 The order of nucleofugality of halogens with iodide 
anion as the attacking species follows the order I > Br > Cl.73 Isotope exchange, i.e. substituting 
a stable iodide atom with a radioactive iodine isotope, is a simple and viable, although a non-
efficient, radioiodination method when high specific activity is not necessary.73 
Nucleophilic substitution via addition-elimination route can also occur in aromatic compounds 
in SNAr mechanism, which requires a leaving group X (≠ H) at the preferred position of 
substitution.86 In addition, the aromatic system must be activated, either by an electron-
withdrawing group (EWG) with –M and/or –I effect in ortho- or para-position to the leaving 
group.73,86 An example electron-withdrawing group is a nitro or a carbonyl group, and the 
purpose of the EWG is to stabilize the negative charge to give rise to the transition state, a 
resonance-stabilized sigma complex. The aromatic system can also be activated  by a suitable 
catalyst, such as a metal salt.73 The leaving group in SNAr reactions is typically a halide, and 
nucleofugality order of halides in  SNAr reactions is F > Cl ≈ Br > I, a reverse order compared 
to SN2 reactions of aliphatic halides.
87 The rate-limiting step is the attack of the nucleophile, 
the following formation of the tetrahedral transition state and the breaking of the aromatic 
system. A simplified (i.e. without all the resonance forms illustrated), schematic of SNAr 
mechanism with the electron-withdrawing group in ortho-position is illustrated in Figure 9. 
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Figure 9. A schematic of SNAr mechanism. All the possible resonance forms are not illustrated.  
3.4.2. Electrophilic substitution 
In electrophilic substitution a positively charged electrophile attacks an electron-rich system: 
as a result, a covalent bond is formed and and a positively charged leaving group is 
disconnected.86 A typical leaving group in electrophilic substitution is a weak Lewis acid that 
is capable of existing without the pair of electrons needed to completely fill the outer electron 
shell: example of such a leaving group is a proton or, less commonly, a metal ion.73 At least 
four major mechanisms are recognized: SE1, SE2 and SEi for aliphatic compounds, and SEAr 
for aromatic compounds. However, most electrophilic radioiodination reactions revolve around 
the SEAr mechanism, and aliphatic electrophilic radioiodinations are less common, nucleophilic 
substitution being the vastly more commonly exploited mechanism for radioiodinating aliphatic 
compounds.73  
Since positively charged iodine cannot exist in condensed form, in electrophilic 
radioiodinations the attacking species is a dipole, δ+I – Xδ-, where X is an electron-withdrawing 
group.73 The formation of electrophilic iodine requires an oxidizing reagent: examples of such 
reagents that are commonly applied are N-chloroamides, Iodogen™ and peracids.73 A SEAr 
mechanism with electrophilic iodine, where Y is a leaving group and X an electron-withdrawing 
group, is illustrated in Figure 10. 
 
Figure 10. SEAr mechanism with electrophilic iodine. 
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3.4.3. Halogenations of aliphatic alkenes and alkynes 
Halogens may be added to aliphatic alkenes and alkynes via addition reactions, and in the scope 
of this study additions of hydrogen halides or diatomic halogens are discussed. The reaction 
pathway resembles electrophilic substitutions, requiring a dipole as an attacking species.86 
Hydrogen halides natively exhibit dipole properties, and diatomic halogens may be polarized 
to induce a dipole in the molecule. The mechanism is initiated by an electrophilic attack, leading 
to formation of a positively charged intermediate, which then traps the nucleophile.86 Additions 
of  hydrogen halides and diatomic halogens are stereoselective. Hydrogen halide additions 
follow the Markovnikov rule; the hydrogen attacks  the carbon with the least substituents. 
Additions of diatomic halogens lead to the formation a halonium ion, in which the positive 
charge is carried by the halogen atom and that are highly reactive due to the ring strain of the 
three-membered ring.  The positively charged intermediate then captures the nucleophile, 
leading to the product. The mechanism with diatomic halogens proceeds via anti addition.86 
Reaction mechanisms of a hydrogen halide and diatomic halogen additions to an alkyne are 
demonstrated in Figure 11. 
 
Figure 11. Addition mechanisms of a hydrogen halide and a diatomic halogen to an alkyne. 
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 Experimental work 
 Aim of the study 
Utilizing PET and SPECT in multimodality imaging of plants has notable potential which is 
yet to be fully realized, mostly due to limited research on suitable instrumentation and 
molecular tracers. The experimental part of this study describes the optimization of a 
radioiodination method for alkynes and testing the method on sugar analogues that are potential 
molecular tracers for studying plant carbohydrate metabolism with multimodality imaging. The 
metabolic incorporation of  6-deoxy-alkynyl glucose into plant cell walls in the root hair tips of 
Arabidopsis thaliana has been reported88, in addition to the synthesis of a suite of similar 
alkynyl sugars89. The sugar analogues used in this study are similar alkynyl derivatives of D-
glucose, and the alkynyl moiety is the targeted region of the radioiodination. Stereoselective, 
acid-catalyzed one-pot iodination method of alkynes with stable iodine leading to a di-iodinated 
product at 60 % yield has been reported90,91, and the radioiodination method developed in this 
study seeks to exploit this particular reaction. Radioiodinations are typically carried out by 
aromatic substitution reactions, but since the carbohydrates found in plant cell walls do not 
generally contain aromatic structures, the aromatic ring would need to be separately 
incorporated into the molecule, which could affect the in vivo behavior of the compound due to 
increased steric bulk and interactions with the aromatic system. An alkynyl group has less steric 
bulk, and the formed iodine-aliphatic sp2-carbon -bond is almost as stable as one with an 
aromatic sp2-carbon73: thus, in terms of in vivo stability, the products are expected to be 
comparable to those produced by  aromatic substitution, and the natural in vivo behavior of the 
compound is assumedly less affected by an additional iodoalkene moiety than an aromatic 
system. Iodine has radioisotopes with PET and SPECT compatible emissions, so the labelling 
procedure may be executed by using an iodine isotope suitable for the preferred/available 
imaging modality. 
The experimental aim of this study was to develop a reasonably quick, selective, high-yield 
radioiodination method for sugar analogues with a terminal alkyne moiety and to characterize 
the main product(s). The experimental part consisted of optimizing the reaction conditions for 
iodination of a terminal alkyne by an ion exchange resin mediated reaction, comparison of this 
reaction to electrophilic substitution, and purification and characterization of the labelled sugar 
analogues. Reaction condition optimization was carried out using 4-phenyl-1-butyne, a cheap, 
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easily obtainable terminal alkyne that was expected to behave in a similar way as the sugar 
analogues, and the parameters optimized were reaction temperature, carrier amount, solvent, 
activation of the ion exchange resin, and minimizing the amount of water in the reaction 
mixture. After determining the optimal reaction conditions, the reaction was compared to 
electrophilic substitution using the same precursor. Finally, the radioiodination method was 
tested on sugar analogues for assessing radiochemical yield and characterization of the main 
product.  
A report of the studied reaction suggest that the reaction is mediated by an in situ formed 
hydrogen iodide species87, which, when reacting with an alkyne, would lead to an addition 
reaction, the main product of which being a monoiodinated Markovnikov product. However, 
the reported main product of the reaction is a di-iodinated species, suggesting the involvement 
of an in situ formed molecular iodine species.90,91 Furthermore, the implication of the 
involvement of in situ formed molecular iodine suggests that electrophilic iodine I+ may be 
present in the reaction mixture, and therefore one possible reaction product is a monoiodinated 
species resulting from an electrophilic substitution reaction between an alkyne and electrophilic 
iodine. A generalized reaction scheme of the studied iodination reaction is illustrated in Figure 
12. 
 
Figure 12. Generalized reaction scheme of the iodination reaction presenting possible iodinated 
products. 
4.1.1. Reaction yield 
Radionuclides used in molecular imaging characteristically have relatively short half-lives, 
which must be considered when working on a radiolabeling method. Ideally the method is 
quick, efficient and repeatable, so that high radiochemical yields may be consistently achieved 
in a short time as possible to minimize product loss due to decay during the labelling. The 
radioisotope used in this study was 125I, whose half-life, 59.4 d, is long enough that no 
significant product loss due to radioactive decay occurs during the labeling. However, 125I’s 
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decay properties are unsuitable for in vivo studies, and the method needs to be suited for shorter-
living radioisotopes of iodine: hence, the maximum time allocated to the reaction part of the 
labelling method in this study was 1 hour. This is the amount of time the sample spends in a 
heated shaker, and during which the majority of the product is formed. To minimize product 
loss due to radioactive decay when labeling with shorter-living radioisotopes of iodine, reaction 
time could not be extended beyond the one-hour limit, and the reaction conditions needed to be 
optimized in other ways in order to maximize the radiochemical yield.  
Generally, reaction rates may be increased, to a certain extent, by increasing the reaction 
temperature. Previous studies on the Dowex®-mediated iodination of alkynes were conducted 
by leaving the reaction mixture to react in 65 °C overnight. 90,91 However, reaction times of 
radioiodinations must be significantly shorter than overnight, and it was suspected that 
increasing the reaction temperature to increase the reaction rate could lead to improved reaction 
yields during the 1 h reaction time. However, evaporation or decomposition of reactants, 
products or solvents may occur at high temperatures, and therefore the reaction temperature 
needs to be tested thoroughly to optimize the reaction conditions.  
Typically, iodinations with non-radioactive iodine may be carried out by using an excess of 
iodine to maximize the reaction yield, but this approach is not suitable for radioiodinations, 
since the non-radioactive iodine will compete with radioiodine, which in turn may lead to low 
RCY and molar activity. Radioiodinations, however, typically utilize such a small amount of 
radioiodine that non-radioactive iodine needs to be added as carrier to ensure that the 
radioiodine behaves as expected. The optimal amount of carrier iodine was therefore set as one 
of the optimization parameters.  
Presence of water in the reaction mixture was assumed to be disadvantageous to the reaction 
yield due to water’s nucleophilic properties, which may interfere with the behavior of 
electrophilic iodine species and lead to dissociation of the HI species suspected to be involved 
in the addition reaction route; therefore, the evaporation of excess water in the samples was 
selected as an optimization parameter.  
A previous report of the reaction suggests that the Dowex® resin used to facilitate the reaction 
could be activated with hydrochloric acid prior to drying, leading to an improved reaction 
yield87; HCl activation of Dowex® was thus set as an optimization parameter.  
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In summary, the parameters in reaction yield optimization were set to be reaction temperature, 
amount of carrier, removal of excess water, and HCl activation of Dowex® resin. In addition, 
the solvent of choice was expected to effect on reaction yield, although the solvent was a more 
essential parameter for studies involving product selectivity. 
4.1.2. Product selectivity 
The Dowex®-mediated reaction using 4-phenyl-1-butyne as precursor is suggested to yield 
three possible reaction products, which from now on will be referred to as 1, 2 and 3. The actual 
mechanism of the reaction remains ambiguous90,91, and the following assumptions about the 
identity of the reacting species are based on the structure of the product. 1 is assumed to be the 
product of an electrophilic substitution reaction with electrophilic iodine I+. 2 is the expected 
Markovnikov product formed in an addition reaction with in situ formed hydrogen iodide, and 
3 is assumed to be an addition product of in situ formed molecular iodine. Structural formulas 
of these products are illustrated in Figure 13. 
 
Figure 13. Structural formulas of reaction products (from left to right): 1 ((4-iodobut-3-yn-1-
yl)benzene), 2 ((3-iodobut-3-en-1-yl)benzene), 3 (((E)-3,4-diiodobut-3-en-1-yl)benzene). 
Due to its electronegativity and ionic radius, the iodide group is assumed to behave much like 
a methyl group: thus, the position and number of substitutions/additions may significantly affect 
the labelled compounds in vivo behavior. In addition, the degree of s character of the carbon in 
a C–I bond may significantly affect the bond strength and the compound’s in vivo stability. 
Selectivity towards a single product and the possibility to modify the conditions to control the 
product formed are therefore desired properties of a labelling method: higher radiochemical 
purity may be achieved when there is only one single product formed, and the possibility to 
control the formed product is highly beneficial when in vivo behavior and stability vary 
significantly between different radiochemical species. 
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A previous study on the Dowex®-mediated reaction suggested a connection between the 
selected solvent’s protic properties and product selectivity.87 Polar, organic solvents with 
differing protic properties were selected as candidates for studies involving product selectivity. 
4.1.3. Radioiodination of sugar analogues 
The ultimate goal of the study was a radioiodinated sugar analogue that could be labelled with 
a suitable isotope of iodine to study carbohydrate metabolism in plants by SPECT or PET 
combined to a structural imaging modality. Two D-glucose analogues were selected as 
precursors for the study. Structural formulas of the precursors (from now on referred to as 4 
and 2) are illustrated in Figure 14.  
 
Figure 14. Structural formulas of 4 (1-(prop-2-yn-1-yloxy)-2,3,4,6-tetra-O-acetyl-D-glucose; 
left) and 5 (1,3-di-(prop-2-yn-1-yloxy)-2,4,6-tri-O-acetyl-D-glucose; right). 
Propargyl groups are the targeted radioiodination moieties and replace some of the hydroxyl 
groups of the sugar analogues: at 1-position for 4, and at 1- and 3-positions for 5. In addition, 
the remaining hydroxyl groups are protected as acetyl groups to prevent unwanted side 
reactions during labeling. 
 Methods and materials 
4.2.1. Materials 
The list of commercially available materials used in this study is presented in Table 7. The 
propargyl sugars are not listed due to not being commercial products: they were synthesized by 
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Dr. Filip Ekholm from University of Helsinki, who kindly provided them for the purpose of 
developing the labeling method. 
Table 7. List of commercially available materials used in this study. 
Product name CAS number Manufacturer 
4-Phenyl-1-butyne, 97 % 16520-62-0 Sigma-Aldrich 
Dowex® 50WX8 hydrogen form 69011-20-7 Sigma-Aldrich 
2-Propanol, anhydrous, 99.5 % 67-63-0  Sigma-Aldrich 
Cyclohexanol, ReagentPlus®, 99 % 108-93-0  Sigma-Aldrich 
Dimethyl sulfoxide, anhydrous, ≥99.9 % 67-68-5 Sigma-Aldrich 
N,N-Dimethylformamide, anhydrous, 99.8 % 68-12-2 Sigma-Aldrich 
Sodium thiosulfate, purum p.a., anhydrous, ≥98.0 % 7772-98-7 Sigma-Aldrich 
Sodium iodide 7681-82-5 N/A 
Na125I, radiochem. purity 98.0 %, molar act. 80.48 
GBq/mmol (carrier-free), in 0.1 M NaOH 
N/A PerkinElmer 
Chloramine T trihydrate, 98 % 7080-50-4 Sigma-Aldrich 
Pierce™ Iodination tubes, 12 mm x 75 mm 51592-06-4 
(Iodogen®) 
Thermo-Fischer 
Scientific 
4.2.2. Radioiodination optimization 
The sugar analogues were available in limited amounts: therefore, the optimization of the 
iodination method was carried out using 4-phenyl-1-butyne as the precursor under the 
assumption that adjusting the reaction parameters will lead in analogous results in terms of 
product yield and selectivity when using the sugar analogues as precursors. The labelling 
reaction parameters under optimization were: reaction temperature, carrier amount, solvent, 
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activation of the ion exchange resin, and minimization of water in the reaction mixture. All the 
experiments concerning labelling optimization were carried out according to the labelling 
method described above, unless stated otherwise. 
4.2.2.1. Labelling method with Dowex® resin 
The initial labelling method before optimization is described below. Concentration of Na2S2O3 
solution was selected as such that an excess of Na2S2O3 compared to added carrier and 
125I could 
be added in 0.5 µL, (i.e. 3.0 µmol of NaI added -> 4µmol of Na2S2O3 added -> concentration 
of Na2S2O3 solution 8 µmol/µL). Dowex
® and NaI were oven-dried for 20 hours in 120 °C 
before use. 
50.0 ±0.5 mg of oven-dried Dowex® resin was weighed into an Eppendorf tube. 0.5 µL of 
aqueous NaI solution (1.2 – 5.0 µmol of NaI) and 400 µL of solvent were pipetted into the tube, 
the tube was closed, and the reaction mixture was vortexed. 10.8 µL of 4-phenyl-1-butyne (76.8 
µmol) and 0.5 µL of 125I solution (~0.5 MBq) was pipetted into the tube, and the reaction 
mixture was vortexed. The reaction mixture was placed into a heated shaker and was left to 
react in 70 – 120 °C for 1 h on 160 rpm shaking speed. The reaction mixture was cooled down 
to RT and the reaction was quenched with 0.5 µL of Na2S2O3 solution. The reaction mixture 
was vortexed and was left to settle until the supernatant could be transferred into a clean tube 
by pipetting. HPLC samples and a TLC plate were prepared from the reaction mixture for 
analysis of results. 
4.2.2.2. Resin activation 
The effect of resin activation was tested by comparing the radiochemical yields of sample 
batches prepared using HCl-activated and non-activated resin. Activation of the resin was 
carried out by stirring 25 g of resin in 50 mL 2 M HCl for 0,5 hrs in room temperature, filtering 
the mixture and washing the residue with milli-Q –water until the pH of the filtrate was neutral. 
HCl-activated Dowex® was oven-dried for 20 hours in 120 °C before use. 
4.2.2.3. Amount of I- carrier 
The effect of carrier amount was tested with three different amounts of carrier: 1.2, 3.0 and 5.0 
µmol of NaI per sample. The carrier was introduced to the reaction mixture in the form of a 
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solution that was prepared from oven-dried solid NaI dissolved in milli-Q –water, and whose 
concentration was such that the desired amount of carrier could be added to the reaction mixture 
in 0.5 µL of the solution (i.e. for adding 1.2 µmol of NaI to the reaction mixture, a 2.4 µmol/µL 
solution was prepared). Samples for testing the effect of carrier amount were prepared with 
HCl-activated Dowex®. 
4.2.2.4. Reaction temperature 
The effect of reaction temperature on reaction yield was tested in three different temperatures: 
70, 95 and 120 °C. Samples for testing the effect of carrier amount were prepared with HCl-
activated Dowex® and 3.0 µmol of carrier. 
4.2.2.5. Solvent 
Four polar, organic solvents with differing protic properties were selected as candidates for 
assessing the effect solvent on reaction yield and product selectivity. The solvent effect tests 
were conducted by preparing the samples for resin activation, carrier amount and reaction 
temperature tests in these selected solvents.  
4.2.2.6. Removal of excess water 
The effect of minimizing water amount in the reaction mixture was carried out by comparing 
the radiochemical yields of samples from which excess water was evaporated prior to reaction 
vs. samples upon which such procedure was not executed. Water evaporation was carried out 
by slightly modifying the labelling method so that the carrier solution was added right after 
weighing the resin in the tube, and water in the solution was evaporated before adding liquid 
reagents to the reaction mixture. A more detailed description is described below. 
4.2.3. Optimized labelling method with Dowex® resin 
The labeling method after optimization is described below:  
50.0 ±0.5 mg of oven-dried Dowex® resin was weighed into an Eppendorf tube. 0.5 µL (3.0 
µmol) of aqueous NaI solution was pipetted on the walls of the tube, and the open tube was 
placed into a heating block for ~5 minutes, until the water had evaporated. 400 µL of 
cyclohexanol was pipetted into the tube, the tube was closed, and the reaction mixture was 
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vortexed. 10.8 µL of 4-phenyl-1-butyne (76.8 µmol) and 0.5 µL of 125I solution (~0.5 MBq) 
was pipetted into the tube, and the reaction mixture was vortexed. The reaction mixture was 
placed into a heated shaker and was left to react in 95 °C for 1 h on 160 rpm shaking speed. 
The reaction mixture was cooled down to RT and the reaction was quenched with 0.5 µL (4 
µmol) of Na2S2O3 solution. The reaction mixture was vortexed and was left to settle until the 
supernatant could be transferred into a clean tube by pipetting. HPLC samples and a TLC plate 
were prepared from the reaction mixtures for analysis of results. 
4.2.4. Comparison to electrophilic substitution 
The Dowex®-mediated radiolabeling reaction was compared to electrophilic substitution 
reactions using Chloramine-T and Iodogen™ as facilitating agents. The samples were prepared 
using the optimized method described above, with the following exceptions: no Dowex® was 
used in the samples with Chloramine-T or Iodogen™; samples with Chloramine-T were 
prepared by pipetting 10 µL of 0.1 mg/µL Chloramine-T solution into an Eppendorf tube and 
evaporating the water; and samples with Iodogen™ were prepared in Pierce™ Iodination Tubes 
coated with Iodogen™. HPLC preparates and a TLC plate were prepared from the reaction 
mixtures for analysis of results. 
4.2.5. Radioiodination of sugar analogues 
The radioiodination of sugar analogues was executed according to the optimized labeling 
method, using ~10 mg of precursor. For characterization of the main product, the procedure 
was upscaled and executed without the addition of 125I, the main product separated with HPLC, 
and analyzed with a 400 MHz NMR spectrometer. 
4.2.6. Analysis 
The samples obtained were analyzed using two different methods: a quick, qualitative method 
using a FLA scan of a TLC plate prepared from the samples, and a more sensitive, quantitative 
HPLC method. The HPLC method was used to characterize and quantify the obtained 
radiochemical products, and TLC was used to qualitatively confirm the results acquired by 
HPLC.  
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4.2.6.1. TLC/FLA 
The TLC plate was prepared by pipetting 0.5 µL of the sample on a normal-phase, silica coated 
aluminum plate. The plate was then eluted with hexane, and after elution left to dry for 20 min 
in RT. The plate was then placed in a plastic zip-lock bag and placed in a FLA cassette. The 
imaging plate was placed on top of the TLC plate and left to expose from 4 hours to overnight. 
After sufficient exposure the imaging plate was analyzed with a FLA scanner. 
4.2.6.2. HPLC 
A HPLC method was developed for separating and quantifying the radioiodinated products. 
Samples were prepared for HPLC analysis by diluting a 40 – 50 µL aliquot of sample in 200 
mL of ACN:H2O (50:50) and filtering the preparate using a 0.2 µm PVDF syringe filter. 100 
µL of preparate was the manually injected into the HPLC system with a Hamilton syringe; for 
some runs the injection volume was increased to provide more reliably quantifiable results. An 
UV-Vis detector and a NaI radiodetector were used for detection.  Essential HPLC parameters 
are listed in Table 8, and a HPLC gradient curve representing ACN concentration over run time 
is illustrated in Figure 15. 
Table 8. HPLC parameters of the analysis method used in the study. 
Column SymmetryPrep C18 7µm, 7.8 x 300 mm 
Eluent ACN:H2O 
Gradient 50:50->90:10 
Flow rate 3 mL/min 
Run time 25 min 
UV-detection wavelengths 210 and 254 nm 
Injection volume 100 µL 
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Figure 15. HPLC gradient curve representing ACN concentration (%) over run time. 
Characterization of the radioiodination products of 125I-iodination of 4-phenyl-1-butyne was 
based on HPLC analysis of samples of 1, 2 and 3, whose identities were confirmed with LC-
MS and NMR. This analysis was conducted in reverse-phase conditions using a C18 column, a 
50:50->100:0 ACN:H2O gradient, 3 mL/min flow rate and UV detection at 210 and 254 nm. In 
these conditions the retention times for 1, 2 and 3 were 9.4, 11.3 and 14.4 min, respectively, 
and the elution order was assumed to be the same under the conditions described in Table 8. A 
reference sample of 3 was analyzed in the conditions described in Table 8: in these conditions, 
the retention time of 3 was 19.56 min, and 1 and 2 were characterized by comparing their elution 
order to that of 3. 
4.2.6.3. Equations and statistical methods 
The equations and statistical methods used in processing the experimental results are presented 
here. Radiochemical yield for a single radiochemical product was calculated according to 
Equation 3: 
RCY =
Aprod
Atot
 
Equation 3 
where Aprod is the measured activity of the radiochemical product, and Atot is the measured 
activity of all radiochemical species and free radioiodine in the sample. Total yield of all 
radiochemical products was calculated according to Equation 4: 
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𝑅𝐶𝑌𝑡𝑜𝑡 = ∑
𝐴𝑖
𝐴𝑡𝑜𝑡
𝑛
𝑖=1
 
Equation 4 
where Ai is the measured activity of a radiochemical product. Standard deviation was calculated 
according to Equation 5: 
𝑠 = √
∑ (𝑥𝑖 − ?̅?)2
𝑛
𝑖=1
(𝑛 − 1)
 
Equation 5 
where x is the observed sample value, x̄ is the arithmetic mean, and n is the number of samples. 
Standard error was calculated according to Equation 6: 
𝑠?̅? =
𝑠
√𝑛
  
Equation 6 
where s is the standard deviation and n is the number of samples. Statistical analysis was 
conducted by using a two-tailed T-test assuming equal variances, when number of groups was 
two, and a two-tailed, single factor ANOVA, when number of groups was three or more; P 
≤0.05 was considered statistically significant. 
 Experiment timeline 
Timeline and reaction parameters of the experiments are presented in Table 9 
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Table 9. Experiment timeline. 
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 Results and discussion 
 Optimization of the radioiodination method 
The results for labeling optimization are presented in this chapter. The error bars in the graphs 
represent the standard error of mean. Quantitative results are based on radio-HPLC analysis of 
the samples. Retention time of 3 was determined by analysis of a reference sample of 3, and 1 
and 2 were identified by their expected elution order of 1, 2 and 3. A summary of the 
optimization results can be found in Attachment 1. Radio-HPLC results of method 
optimization. A radio-HPLC chromatogram demonstrating the retention times of free 125I-, 
[125I]1, [125I]2 and [125I]3 is presented in Figure 16. 
 
Figure 16. Radio-HPLC chromatogram demonstrating the retention times of free 125I- (2.429 
min), [125I]1 (11.638 min), [125I]2 (13.342 min) and [125I]3 (19.559 min). The radiopeak at 3.626 
min appeared inconsistently in the chromatograms and is most likely caused by interference. 
The sample that the chromatogram represents was prepared under the following conditions: 
reaction time 60 min, solvent cyclohexanol, reaction temperature 70 °C, amount of carrier 3.0 
µmol, Dowex® HCl-activated, no excess water evaporated. This particular chromatogram was 
selected as an example, because it shows clearly all the relevant radiopeaks, i.e. those associated 
with free 125I-, [125I]1, [125I]2 and [125I]3. 
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5.1.1. Resin activation 
The effect of Dowex® HCl activation on the amount of formed 125I-labeled products was tested 
in different solvents in two separate sample batches, the other prepared with non-activated resin 
and the other with HCl-activated resin: the assumption was that using HCl-activated Dowex® 
leads to higher yield of radiochemical products than when using non-activated Dowex®. The 
samples in were prepared in triplicate in 70 °C with 1.2 µmol of carrier. The results are 
presented as the average of the sum of all radioiodinated products in in Figure 17. 
 
Figure 17. The effect of Dowex® HCl activation on the amount of formed 125I-labeled products 
in 125I -iodination of 4-phenyl-1-butyne in different solvents. In cyclohexanol and DMSO a 
slight decrease in formation of radioiodinated products is observed due to the activation, from 
28.3 ±3.6 to 23.4 ±4.7 % and from 12.9 ±4.3 to 6.4 ±3.4 %, respectively, whereas in 2-propanol 
and DMF the effect is opposite, and the amount of radioiodinated products is increased from 
50.1 ±0.5 % to 57.3 ±14.2 % and from 0 % to 4.47 ±0.4 %, respectively. 
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In cyclohexanol and DMSO, the amount of formed radioiodination products decreased with 
Dowex® HCl activation; however, it should be noted that the final reaction time for the batch 
without HCl-activated Dowex® was 15 min longer, which may have led to the higher yield. For 
2-propanol the effect of Dowex® HCl activation was opposite, and in DMF the test batch 
without HCl-activated Dowex® yielded no quantifiable amounts of radioiodinated products. 
Dowex® HCl activation did not lead to a statistically significant increase in amount of formed 
radioiodination products in any of the solvents used. However, there are reports that comparable 
or even higher yields have been obtained with HCl-activated Dowex®90, so activation was 
carried out in further experiments.  
5.1.2. Amount of I- carrier 
The effect of the amount of I- carrier on the amount of formed 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne was tested with three separate sample batches and in four 
different solvents. The samples were prepared in triplicate in 70 °C with 60 min reaction time 
and with HCl-activated Dowex®. The results are presented as the average of the sum of 
radioiodinated products in each sample in Figure 18. 
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Figure 18. The effect of I- carrier amount on the amount of formed 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in different solvents. In cyclohexanol and DMSO the highest 
yield of radioiodinated products was obtained with 3.0 µmol of NaI carrier (39.4 ±8.6 % and 
11.0 ±1.1 %, respectively), while in 2-propanol and DMF the highest yield of radioiodinated 
products was achieved with 5.0 µmol of NaI (69.3 ±9.9 %  and 5.3 ±1.1 %, respectively). 
In cyclohexanol and DMSO, using 3.0 µmol of I- carrier resulted in the highest average yield 
of radioiodinated products. In 2-propanol and DMF the highest average yield of radioiodinated 
products was achieved with 5.0 µmol of I- carrier. In cyclohexanol the amount of I- carrier had 
a statistically significant effect on the amount of radioiodinated products formed, while in the 
other tested  solvents the effect was not statistically significant. Further experiments were 
carried out using 3.0 µmol of I- carrier. 
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5.1.3. Reaction temperature 
The effect of reaction temperature on the amount of formed 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne was tested with three separate sample batches and in four 
different solvents.  The samples were prepared in triplicate with 60 min reaction time, 3.0 µmol 
of I- carrier and HCl-activated Dowex®. The results are presented as the average of the sum of 
radioiodinated products in Figure 19. 
 
Figure 19. The effect of reaction temperature on the amount of formed 125I-labeled products in 
125I-iodination of 4-phenyl-1-butyne in different solvents. In cyclohexanol, DMSO and DMF 
the highest yields of radioiodinated products were achieved in 120 °C (74.4 ±7.4 %, 45.9 ±2.3 
% and 14.0 ±0.5 %, respectively); in 2-propanol the highest yield of radioiodinated products, 
61.6 ±6.8 %, was achieved in 70 °C. 
The highest amount of radioiodinated products was formed in 120 °C, except in 2-propanol, in 
which the highest amount of radioiodinated products was achieved in 75 °C . Results for 2-
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propanol in 120 °C could not be obtained due to 2-propanol’s boiling point of 82.5 °C, which 
led to almost complete solvent evaporation in 120 °C: thus, the amount of formed 
radioiodinated products could not be measured in these conditions. Variance analysis suggested 
the reaction temperature has a statistically significant effect on formation of radioiodinated 
products, except in 2-propanol, where such an effect could not be observed. Due to working 
safety concerns (the Eppendorf tubes used in the study have a nominal heat tolerance up to 100 
°C92) further experiments were carried out in 95 °C. 
5.1.4. Solvent 
125I-iodination of 4-phenyl-1-butyne was tested in four different solvents to study the solvent’s 
effect on regioselectivity of the radioiodination and the radiochemical yield of individual 
products. Effect of reaction parameters on yield of radioiodinated products has been discussed 
earlier, and this section is more focused on product selectivity. The study on solvent effects 
used the same data set obtained in reaction temperature and carrier tests, and the results are 
presented as an average of the radiochemical yields of individual products, summed into a 
single column. 
5.1.4.1. Cyclohexanol 
The effect of amount of I- carrier on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in cyclohexanol is illustrated in Figure 20. The samples were prepared in 
triplicate, using HCl-activated Dowex® in 70 °C reaction temperature and 60 min reaction time. 
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Figure 20. The effect of amount of I- carrier on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in cyclohexanol. Highest RCY and regioselectivity were 
achieved with 3.0 µmol of I- carrier, and yielded in main product [125I]3 at 30.8 ±5.8 % yield 
and a total yield of radiochemical products of 39.4 ± 5.0%. 
The results display a tendency to favor the di-iodinated [125I]3 when 3.0 µmol of carrier was 
used, and the sum of average radiochemical yields was also highest under these conditions. 
With 1.2 and 5.0 µmol of carrier the results were highly similar in terms of product distribution 
and yield.  
The effect of reaction temperature on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in cyclohexanol is illustrated in Figure 21. The samples were prepared in 
triplicate, using HCl-activated Dowex®, 3.0 µmol of I- carrier and 60 min reaction time. 
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Figure 21. The effect of reaction temperature on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in cyclohexanol. Highest RCY and product selectivity were 
achieved in 120 °C: main product yield [125I]3 was 74.4 ±7.4 %, with no other radioiodinated 
chemical species present in measurable amounts. 
In 70 and 95 °C the results are highly similar in terms of product distribution and amount of 
formed radioiodinated products, the favored product being [125I]3. In 120 °C the results display 
a significantly increased yield, as well as a complete selectivity towards [125I]3. A radio-HPLC 
chromatogram and associated peak data demonstrating the high yield and selectivity achieved 
in cyclohexanol in 120 °C is presented in Figure 22. 
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Figure 22. Radio-HPLC chromatogram and associated peak data of a sample prepared in 
cyclohexanol, in 120°C, using HCl-activated Dowex®, 3.0 µmol of I- carrier and 60 min 
reaction time. [125I]3 peak with an area corresponding to 78.154 % RCY is found at 19.753 min. 
A noticeable feature in the chromatogram is the absence of the radiopeak associated to free 
radioiodine. In addition, a peak associated with an unidentified radioiodination side product can 
be found at 8.023 min; this side product appeared inconsistently in the samples, typically in low 
yields, and was thus left unidentified. 
5.1.4.2. DMSO 
The effect of amount of I- carrier on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in DMSO is illustrated in Figure 23. The samples were prepared in triplicate, 
using HCl-activated Dowex® in 70 °C reaction temperature and 60 min reaction time. 
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Figure 23. The effect of amount of I- carrier on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in DMSO. With all tested carrier amounts the reaction favored 
the di-iodinated product [125I]3, with no other radioiodinated products formed in measurable 
amounts. Highest RCY of [125I]3, 11.0 ±1.1 %, was achieved with 3.0 µmol of carrier. 
In DMSO the reaction appears to have complete selectivity towards [125I]3. However, it should 
be noted that the overall yield was low with all tested amounts of carrier, and other 
radiochemical species may have formed in undetectable and -quantifiable amounts. 
The effect of reaction temperature on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in DMSO is illustrated in Figure 24. The samples were prepared in triplicate, 
using HCl-activated Dowex®, 3.0 µmol of I- carrier and 60 min reaction time. 
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Figure 24. The effect of reaction temperature on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in DMSO. Highest RCY and product selectivity were achieved 
in 120 °C: RCY of the main product [125I]3 was 38.5 ±0.8 %, and the total amount of formed 
radioiodination products was 45.9 ±1.3 %. 
In DMSO the reaction appears to retain its selectivity towards [125I]3, with some [125I]2 forming 
in quantifiable amounts in 95 and 120 °C. Increasing the temperature resulted in a statistically 
significant increase in the yield of radioiodinated products.  
5.1.4.3. 2-propanol 
The effect of amount of I- carrier on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in 2-propanol is illustrated in Figure 25. The samples were prepared in 
triplicate, using HCl-activated Dowex® in 70 °C reaction temperature and 60 min reaction time. 
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Figure 25. The effect of amount of I- carrier on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in 2-propanol. Highest RCY and product selectivity were 
achieved with 5.0 µmol of carrier: RCY of the main product[125I]3 was 64.3 ±6.4 %, and the 
total amount of formed radioiodination products was 69.3 ±5.7 %. 
In 2-propanol the reaction displays a rather uniform yield and product distribution with all tested 
amounts of carrier, with notable selectivity towards [125I]3. [125I]2 was detectable only in the 
samples with 1.2 µmol of carrier: however, the detected amount was relatively low, and it can 
be assumed that [125I]2 was formed in unquantifiably small amounts with all tested amounts of 
carrier. 
The effect of reaction temperature on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in 2-propanol is illustrated in Figure 26. The samples were prepared in 
triplicate, using HCl-activated Dowex®, 3.0 µmol of I- carrier and 60 min reaction time. 
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Figure 26. The effect of reaction temperature on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in 2-propanol. Highest amount of formed radioiodination 
products, 57.3 ±5.9 %, was achieved in 95°C; however, RCY of the main product [125I]3 does 
not differ significantly between 70 °C and 95 °C (54.7 ±5.4 and 52.1 ±10.8 %, respectively). 
The reaction temperature does not appear to have a significant effect on product distribution or 
radiochemical yield in 2-propanol. The favored reaction product is [125I]3, with small amounts 
of [125I]1. [125I]2 was detected in 95 °C, but as before, the amount was relatively small, and an 
unquantifiably small amount of [125I]2 may be present in samples made in 70 °C. As before 
noted, reaction in 2-propanol could not be tested in 120 °C due to solvent evaporation. 
5.1.4.4. DMF 
The effect of amount of I- carrier on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in DMF is illustrated in Figure 27. The samples were prepared in triplicate, 
using HCl-activated Dowex® in 70 °C reaction temperature and 60 min reaction time. 
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Figure 27. The effect of amount of I- carrier on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in DMF. Only the di-iodinated product [125I]3 was formed in 
measurable amounts with all carrier amounts, and the highest RCY of [125I]3, 5.32 ±0.8 % was 
achieved with 5.0 µmol of carrier. 
The amount of carrier appears to have an insignificant effect on product distribution and 
radiochemical yield in DMF. The reaction displays a complete selectivity towards [125I]3, 
although it is to be noted that the overall radiochemical yield is low, and other radiochemical 
species may have formed in undetectable and -quantifiable amounts. 
The effect of reaction temperature on formation of 125I-labeled products in 125I-iodination of 4-
phenyl-1-butyne in DMF is illustrated in Figure 28. The samples were prepared in triplicate, 
using HCl-activated Dowex®, 3.0 µmol of I- carrier and 60 min reaction time. 
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Figure 28. The effect of reaction temperature on formation of 125I-labeled products in 125I-
iodination of 4-phenyl-1-butyne in DMF. Only the di-iodinated product [125I]3  was formed in 
measurable amounts in all temperatures, and the highest RCY of [125I]3, 14.0 ±0.3 %, was 
achieved in 120 °C. 
The reaction retains its observable selectivity towards [125I]3 with increasing temperature. 
Significant increase in radiochemical yield is also displayed with increasing temperature. 
5.1.5. Evaporation of excess water 
The effect of evaporating excess water from the samples on amount of formed radioiodinated 
products was studied with two sample batches, the other prepared with excess water evaporation 
and the other without. The samples were prepared in triplicate in cyclohexanol, using HCl-
activated Dowex®, 3.0 µmol of carrier and 95 °C reaction temperature. The results are presented 
in Figure 29. 
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Figure 29. The effect of evaporation of excess water on the amount of formed radioiodination 
products in 125I-iodination of 4-phenyl-1-butyne in cyclohexanol. The only radioiodination 
product formed in these conditions was [125I]3, and an increase in RCY of [125I]3was observed 
when excess water was evaporated from the sample: RCY of [125I]3 increased from 64.6 ±6.3 
% to 75.5 ±4.5 when excess water was evaporated. 
The results display an observable increase in the amount of formed radioiodination products 
when excess water is removed. However, the difference is not statistically significant.  
5.1.6. Summary of radioiodination method optimization 
Different carrier amounts were tested to study the carrier’s effect on the amount of formed 
radioiodination products. In cyclohexanol and DMSO, 3.0 µmol of carrier resulted in the 
highest amount of 125I-iodinated products, and in 2-propanol and DMF the highest amount of 
125I-iodinated products was reached with 5.0 µmol of carrier. The carrier effect was more 
pronounced in cyclohexanol and DMSO. The amount of carrier did not have a statistically 
significant effect on yield of 125I-iodinated products, except in cyclohexanol, where 3.0 µmol 
of carrier resulted in the highest yield of 125I-iodinated products. The results suggest that carrier 
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amounts higher than 3.0 µmol lead to the carrier competing with 125I in the radioiodination 
reaction, leading to decreased yield of radioiodination products. Amount of carrier was not 
expected to affect regioselectivity of the radioiodination, and neither is this effect observed in 
the data.  
Different reaction temperatures were tested to assess the temperature effect on formation of 
radioiodinated products. In the tested reaction temperatures, the amount of formed 
radioiodination products displayed a statistically significant increase with increasing 
temperature in all solvents (except 2-propanol), and the highest amounts of formed 
radioiodination products were obtained in 120 °C. Reactions in 2-propanol were an exception 
to the aforementioned, and in 2-propanol radiolabelings in 70 °C and 95 °C produced 
comparable and similar yields of radiochemical products. Due to 2-propanol’s relatively low 
boiling point the reaction could not be tested in 120 °C in 2-propanol. Reaction temperature did 
not appear to have an observable effect on regioselectivity of the radioiodination products in 
DMSO, 2-propanol and DMF: in cyclohexanol selectivity towards [125I]3 increased with 
increasing temperature. 
Reactions in protic solvents generally displayed higher radiochemical yields and wider reaction 
product diversity than those in aprotic solvents; however, as noted before, the observed higher 
selectivity in aprotic solvents may simply be a result of an overall low radiochemical yield, and 
other radioiodinated reaction products may have formed, although in undetectable and 
unquantifiable amounts. The reaction displayed regioselectivity towards the same di-iodinated 
product 3 under all conditions, with aprotic solvents being more selective than protic. In 
summary, protic solvents displayed more favorable results than aprotic.  
HCl activation of Dowex® and removal of excess water displayed a slight increase in the 
amount of formed radioiodination products, although the difference was not statistically 
significant in either case. It was, however, decided to integrate these procedures into the sample 
preparation protocol.  
Overall, the repeatability of the radioiodination method seems sufficient, and in the last two 
sample sets prepared under the optimal conditions the standard deviation of  RCY of [125I]3 was 
≤ 10 %. A total of 5 (out of 84) individual samples were rejected due to inconsistent results 
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(e.g. the amount of radioiodinated products was ± 2.5s from the average yield of the sample 
set).  
Highest radiochemical yields were obtained in 120 °C. However, it was decided to set 95 °C as 
the reaction temperature for the rest of the method development, since the sample preparation 
protocol relied on the use of Eppendorf tubes, which have a heat tolerance up to 100 °C. Due 
to 2-propanol’s relatively low boiling point and the reaction yield’s dependence on reaction 
temperature, cyclohexanol was assessed to be the most suitable solvent from the solvents tested. 
However, it must be noted that cyclohexanol’s high viscosity poses a practical issue in sample 
preparation, and additional care must be taken to assure all reagents are mixed and dissolved in 
the reaction mixture. Following the decision to use cyclohexanol as the solvent of choice, 3.0 
µmol of carrier was selected as the carrier amount, since the highest radiochemical yields in 
cyclohexanol were obtained with 3.0 µmol. 
Due to iodine’s volatility, the suspected evaporation of radioiodine during reaction was tested 
twice during the optimization phase, first under the initial conditions and finally under the 
optimized conditions, by taking a 200 µL aliquot of the reaction mixture before and after the 
reaction and measuring the difference in activity between the samples by gamma counting. No 
significant change in radioactivity was observed under either conditions, and it was concluded 
that no significant loss of radioactivity occurred 
 Comparison to electrophilic substitution 
Comparison of the Dowex®-mediated iodination reaction was carried out in the optimized 
reaction conditions using 4-phenyl-1-butyne as the precursor: that is, 3.0 µmol of I- carrier; 95 
°C reaction temperature; cyclohexanol as solvent; and with Dowex® HCl activation and excess 
water evaporated. The test was conducted by preparing the samples in triplicate and with 
differing reaction facilitating agents: Dowex®, Chloramine-T, and Iodogen™. Quantitative 
results are based on HPLC analysis of the samples, and a summary of the comparison results 
can be found in Attachment 1. Radio-HPLC results of method optimization. The results are 
illustrated in Figure 30.  
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Figure 30. Comparison of optimized Dowex®-mediated radioiodination of 4-phenyl-1-butyne 
to electrophilic radioiodinations of 4-phenyl-1-butyne. The highest yields of radioiodinated 
products were achieved by using Dowex® to facilitate the reaction: RCY of the main product, 
[125I]3, was 55.2 ±9.3 % and total RCY 76.8 ±1.6 %. 
Under the test conditions, reactions with Dowex® yielded in a significantly higher 
radiochemical yield of [125I]3 than reactions with electrophilic reagents. [125I]3 dominated in 
the Dowex®-mediated reaction product distribution, whereas samples prepared with 
electrophilic reagents displayed a more even distribution of reaction products. RCYs of [125I]1 
and [125I]2 were quite similar regardless of reaction facilitating used, from 1.9 to 6.2 %, 
implying that the choice of the reaction facilitating agent mostly affects the formation of  [125I]3. 
Selected radio-HPLC chromatograms and the associated peak data of samples prepared with 
Dowex®, Chloramine-T, and Iodogen™ are presented in Figure 31, Figure 32, Figure 33, 
respectively 
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Figure 31. A radio-HPLC chromatogram and associated peak data of a sample prepared with 
HCl-activated Dowex® in cyclohexanol, in 95 °C, with 3.0 µmol of I- carrier and 60 min 
reaction time. [125I]1, [125I]2 and [125I]3 peaks are found at 11.894 min, 13.561 min and 19.693 
min, respectively, [125I]3 being the main product formed at RCY of 66.921 %. Free 125I- peak is 
found at 2.605 min. Small peaks associated with unidentified radioiodination side products can 
be found at 6.719 min and 8.023 min; these side products appeared inconsistently in the 
samples, typically in low yields, and were thus left unidentified. 
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Figure 32. A radio-HPLC chromatogram and associated peak data of a sample prepared with 
Chloramine-T in cyclohexanol, in 95 °C, with 3.0 µmol of I- carrier and 60 min reaction time. 
[125I]1, [125I]2 and [125I]3 peaks are found at 11.913 min, 13.624 min and 19.722 min, 
respectively. [125I]3 was formed in relatively small amounts in this sample (4.363 %), compared 
to those prepared with HCl-activated Dowex®, [125I]1 being the main product at RCY of 5.803 
%. Free 125I- peak is found at 2.584 min. A peak associated with an unidentified radioiodination 
side product can be found at 8.111 min; this side product appeared inconsistently in the samples, 
typically in low yields, and was thus left unidentified. 
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Figure 33. A radio-HPLC chromatogram and associated peak data of a sample prepared with 
Iodogen™ in cyclohexanol, in 95 °C, with 3.0 µmol of I- carrier and 60 min reaction time. 
[125I]1, [125I]2 and [125I]3 peaks are found at 11.920 min, 13.583 min and 19.641 min, 
respectively. Amount of [125I]3 formed in this sample (10.759 %) was slightly higher than in 
those prepared with Chloramine-T, but significantly lower than in the samples prepared with 
HCl-activated Dowex®. Free 125I- peak is found at 2.620 min. 
 Radioiodination of sugar analogues 
The optimized radioiodination protocol was tested on sugar analogues. The test was carried out 
by preparing triplicate samples from two different acetylated sugar analogues 4 and 5 as 
precursors, utilizing the optimized conditions described before. The samples were analyzed 
with the same HPLC method developed for the optimization phase. Radiochemical yields and 
retention times of the main products of Dowex®-mediated sugar analogue radioiodination are 
presented in Figure 34. 
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Figure 34. Radiochemical yields and retention times of the main products of Dowex®-mediated 
sugar analogue radioiodination. RCY of the main product was slightly higher in samples 
prepared from 5: using 4 as the precursor resulted in [125I]6 with RCY of 49.9 ±2.8 %, whereas 
using 5 as the precursor resulted in [125I]7 with RCY of 56.0 ±5.1 %. 
Tests with each precursor yielded one main product with a yield of 45 – 62 % and a consistent 
retention time, and 2 – 5 side products with low and inconsistent yields. Tests with 5 resulted 
in a slightly higher average yield: however, the difference is not statistically significant. Yields 
with both precursors were consistent, and the radioiodination methods appears to retain its 
repeatability when applied to the sugar analogues in question.  
 Characterization 
To characterize the main product obtained in radioiodination of sugar analogues, samples 
without radioactive iodine were prepared from both aforementioned precursors, using the 
optimized radioiodination protocol upscaled in order to obtain a sufficient amount of main 
product for characterization. The product was separated from the reaction mixture by HPLC 
fractioning, and the eluent was evaporated by first removing the bulk of the eluent by rotary 
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evaporation and then lyophilizing the sample to remove as much of the residual eluent as 
possible, resulting in purified product obtained in a yield of ~1 mg. The samples were dissolved 
in deuterated acetonitrile, CD3CN, and their 
1H-NMR spectra measured with a 400 MHz NMR 
spectrometer, along with reference samples prepared from the non-iodinated precursors. Since 
the results from the optimization phase strongly suggested a di-iodinated product, the reaction 
with sugar analogues was hypothesized to behave similarly and lead to a di-iodinated product. 
In 5 there are two propargyl moieties in which the iodination reaction may occur: the possibility 
of regioselectivity between the moieties was acknowledged, but no hypothesis was made 
concerning the preferred reaction position. 
The characteristic differences in the NMR spectra of 4 and its main reaction product 6 are most 
apparent in the chemical shifts and splitting patterns of protons 6a, 6b and 7. In 4’s spectrum 
protons 6a and 6b display the 16.0 Hz chemical shift of originating from the geminal 2J-coupling 
between the protons, and the 2.4 Hz shift from the propargylic long-range 4J-coupling with 
proton 7. The doublet of doublets splitting pattern further confirms this coupling scheme. In 4’s 
spectrum, proton 7’s chemical shift is assigned as 2.71 ppm, and it’s observed splitting pattern 
is a triplet. The coupling constant 2.4 Hz indicates propargylic 4J-coupling with protons 6a and 
6b. In 6’s spectrum, proton 7’s chemical shift has moved to 7.32 ppm and it’s observed splitting 
pattern has changed into a singlet. However, protons 6a and 6b display, in addition to the 2J-
coupling constant 13.2 Hz, a coupling constant of 0.6 Hz, most likely indicating an allylic 4J-
coupling with proton 7: thus, proton 7’s splitting pattern would be actually a triplet, although, 
likely due to limited resolution, the small coupling constant leads to the observed splitting 
pattern to be a singlet. From precursor to product spectrum, the chemical shift of 6b displays 
an increase of 0.17 Hz, and the chemical shift of proton 1 has decreased by 0.20 Hz, but these 
changes were not considered relevant for characterization. Four singlets with an integral 
corresponding to that of 3 protons can be observed in the 1.87 – 2.00 ppm range in both 
spectrums, indicating that the protecting acetyl groups remained intact during and after reaction. 
In summary, the NMR interpretation supports the hypothesis of a di-iodinated product 6 with 
no other observable structural changes. NMR interpretations of 4 and its main reaction product 
are illustrated in Figure 35. Details of NMR spectra of 4 and 6, demonstrating the characteristic 
structural changes resulting from the iodination reaction, are illustrated in Figure 36 and Figure 
37. 
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1H NMR (400 MHz, Acetonitrile-d3)  
5.18 (t, 3JHH = 9.6 Hz, 1H, H3),  
4.95 (t, 3JHH = 9.8 Hz, 1H, H4),  
4.82 (dd, 3JHH = 9.7, 8.0 Hz, 1H, H2), 
4.72 (d, 3JHH = 8.0 Hz, 1H, H1),  
4.29 (dd, 1JHH = 16.0, 4JHH = 2.4 Hz, 1H, H6b), 
4.23 (dd, 1JHH = 16.0, 4JHH = 2.4 Hz, 1H, H6a), 
4.16 (dd, 1JHH = 12.3, 3JHH = 5.0 Hz, 1H, H11b),  
3.99 (dd, 1JHH = 12.4, 3JHH = 2.5 Hz, 1H, H11a), 
3.76 (ddd, 3JHH = 10.0, 4.9, 2.5 Hz, 1H, H5), 
2.71 (t, 4JHH = 2.4 Hz, 1H, H7),  
1.94 (s, 3H, H12a,b,c), 
1.93 (s, 3H, H8a,b,c),  
1.90 (s, 3H, H10a,b,c), 
1.87 (s, 3H, H9a,b,c). 
1H NMR (400 MHz, Acetonitrile-d3)  
7.32 (d, 4JHH = 0.6 Hz, 1H, H7),  
5.19 (t, 3JHH = 9.6 Hz, 1H, H3),  
4.97 (t, 3JHH = 9.7 Hz, 1H, H4),  
4.87 (dd, 3JHH = 9.8, 8.1 Hz, 1H, H2),  
4.52 (d, 3JHH = 8.1 Hz, 1H, H1),  
4.46 (dd, 1JHH = 13.2, 4JHH = 0.6 Hz, 1H, H6b),  
4.23 (dd, 1JHH = 13.1, 4JHH = 0.6 Hz, 1H, H6a),  
4.18 (dd, 1JHH = 12.3, 3JHH = 5.1 Hz, 1H, H11b),  
4.02 (dd, 1JHH = 12.1, 3JHH = 2.4 Hz, 1H, H11a),  
3.76 (ddd, 3JHH = 10.0, 5.1, 2.5 Hz, 1H, H5),  
1.97 (s, 3H, H12a,b,c),  
1.94 (s, 3H, H8a,b,c),  
1.89 (s, 3H, H10a,b,c),  
1.88 (s, 3H, H9a,b,c). 
Figure 35. NMR interpretations of 4 and its main reaction product, 1-((E)-2,3-diiodo-prop-2-
en-1-yloxy)-2,3,4,6-tetra-O-acetyl-D-glucose (6). The structural differences between the 
precursor and the product can be observed in the chemical shifts of hydrogens 6b and 7, 
indicating the addition of iodine to the triple bond. 
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Figure 36. Details of NMR spectra of 4 (left) and 6 (right). The peak at 7.32 ppm (H7), marked 
with the red arrow in the right-side spectrum and notably absent in the left-side spectrum, 
indicates the di-iodination of the triple bond that results in the shifting of the terminal hydrogen 
peak from 2.70 to 7.31 ppm. The unmarked peak in the right-side spectrum results from solvent 
impurities. 
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Figure 37. Details of NMR spectra of 4 (left) and 6 (right). The doublet at 4.72 (H1) ppm, 
marked with the red arrow in the left-side spectrum, has shifted to 4.52 in the right-side 
spectrum following the structural changes caused by the di-iodination of the triple bond. The 
doublet of doublets (H6b; appearing as a doublet in the figure due to scale) at 4.46 ppm and 
marked with a green arrow in the right side spectrum, has shifted from 4.29 ppm due to the 
structural changes caused by the di-iodination of the triple bond. The three unmarked multiplets 
appearing in both spectrums with unchanged chemical shifts are associated with, from left to 
right, H3, H4 and H2. 
In the NMR spectrum of 5, the propargylic terminal protons 7 and 10 can be observed as triplets 
with a coupling constant of 2.4 Hz and chemical shifts of 2.70 and 2.67 ppm, respectively. 
Protons 6a and 6b display a propargylic 4J-coupling constant of 2.4 Hz in addition to the 
geminal 2J-coupling constant of 16.0 Hz, and protons 9a and 9b display a propargylic 4J-
coupling constant of 2.4 Hz. In 7’s NMR spectrum, the triplet at 2.70 ppm has disappeared and 
replaced by a singlet at 7.31 ppm, while the coupling constants of protons 6a and 6b have 
changed from 16.0 and 2.4 Hz to 13.3 and 0.7 Hz, indicating a similar structural change as with 
4 and its product. However, the triplet at 2.70 ppm is still present in product 7’s spectrum, and 
the chemical shifts of protons 9a, 9b and 3 remain virtually unchanged from precursor to 
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product spectrum, indicating regioselectivity towards one propargyl moiety over the other. A 
similar -0.20 Hz change in the chemical shift of proton 1 is observed as with 4 and its product: 
a comparable change would assumedly be observed in the chemical shift of proton 3 if the 
radioiodination occurred in both propargyl moieties. However, no such change is observed, and 
since proton 3:s coupling constants matches closely to those of protons 4 and 2, it can be 
deduced that no significant structural changes occur in this part of the molecule, and the 
hypothesis of regioselectivity is substantiated further. It should be noted that the expected 
splitting pattern of proton 3 in both spectrums is a doublet of doublets with 3J-coupling 
constants of 10.1 and 9.5 Hz: however, the observed splitting pattern is a triplet, likely due to 
limited resolution. As with 4 and its product, 6, the protecting acetyl groups remain intact, 
according to the three singlets with 3-hydrogen integrals at 1.94 – 2.00 ppm range in the 
precursor spectrum and the singlet with a 9-hydrogen integral at 1.93 – 1.99 ppm range in the 
product spectrum. In summary, the NMR interpretation supports the hypothesis of a di-
iodinated product with no other observable structural changes. In addition, the NMR data 
suggests regioselectivity towards the propargyl moiety in 1-position. NMR interpretations of 5 
and its main reaction product 7 are illustrated in Figure 38. Details of NMR spectra of 5 and 7, 
demonstrating the characteristic structural changes resulting from the iodination reaction, are 
illustrated in Figure 39 and Figure 40. 
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1H NMR (400 MHz, Acetonitrile-d3)  
4.85 (dd, 3JHH = 10.1, 9.3 Hz, 1H, H-4),  
4.72 (dd, 3JHH = 9.5, 8.0 Hz, 1H, H-2),  
4.60 (d, 3JHH = 8.1 Hz, 1H, H-1),  
4.27 (dd, 1JHH = 16.0, 4JHH = 2.4 Hz, 1H, H-6b),  
4.21 (dd, 1JHH = 16.0, 4JHH = 2.4 Hz, 1H, H-6a),  
4.16 (d, 4JHH = 2.4 Hz, 2H, H-9a,b),  
4.10 (dd, 1JHH = 12.3, 3JHH = 5.2 Hz, 1H, H-12b),  
3.96 (dd, 1JHH = 12.3, 3JHH = 2.6 Hz, 1H, H-12a),  
3.72 (t, 3JHH = 9.4 Hz, 1H, H-3),  
3.64 (ddd, 3JHH = 10.1, 5.2, 2.5 Hz, 1H, H-5),  
2.70 (t, 4JHH = 2.4 Hz, 1H, H-7),  
2.67 (t, 4JHH = 2.4 Hz, 1H, H-10),  
2.00 (s, 3H, H-13a,b,c),  
1.99 (s, 3H-8a,b,c),  
1.94 (s, 3H, H-11a,b,c) 
1H NMR (400 MHz, Acetonitrile-d3)  
7.31 (s, 1H, H-7),  
4.87 (dd, 3JHH = 10.1, 9.3 Hz, 1H, H-4),  
4.77 (dd, 3JHH = 9.5, 8.1 Hz, 1H, H-2),  
4.44 (dd, 1JHH = 13.2, 4JHH = 0.7 Hz, 1H, H-6b),  
4.40 (d, 1JHH = = 8.1 Hz, 1H, H-1),  
4.21 (dd, 1JHH = 13.2, 4JHH = 0.7 Hz, 1H, H-6a),  
4.16 (d, 4JHH = 2.4 Hz, 2H, H-9a,b),  
4.13 (dd, 1JHH = 12.3, 1JHH = 5.3 Hz, 1H, H-12b),  
3.98 (dd, 1JHH = 12.2, 1JHH = 2.5 Hz, 1H, H-12a),  
3.73 (t, 1JHH = 9.4 Hz, 1H-3),  
3.64 (ddd, 1JHH = 10.0, 5.3, 2.5 Hz, 1H, H-5),  
2.67 (t, 4JHH = 2.4 Hz, 1H, H-10),  
1.99 – 1.93 (m, 9H, H-8a,b,c-11a,b,c-13a,b,c) 
Figure 38. NMR interpretations of 5 and its main reaction product, (1-((E)-2,3-diiodo-prop-2-
en-1-yloxy)-3-(prop-2-yn-1-yloxy)-2,4,6-tri-O-acetyl-D-glucose (7). The structural differences 
between the precursor and the product can be observed in the chemical shifts of hydrogens 6b 
and 7, indicating the di-iodination of the triple bonf. The chemical shifts of hydrogens 9a, 9b 
and 10 remain unchanged from precursor to product spectra, indicating that no iodination takes 
place in the 3-(prop-2-yn-1-yloxy) moiety. 
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Figure 39. Details of NMR spectra of 5 (left) and 7 (right). The peak at 7.31 (H7) ppm, marked 
with the red arrow in the right-side spectrum and notably absent in the left-side spectrum, 
indicates the di-iodination of the triple bond that results in the shifting of the terminal hydrogen 
peak from 2.70 to 7.31 ppm. The unmarked peaks in the right-side spectrum result from solvent 
impurities and other contaminants.  
 
74 
 
Figure 40. Details of NMR spectra of 5 (left) and 7 (right). The doublet at 4.62 (H1) ppm, 
marked with the red arrow in the left-side spectrum, has shifted to 4.40 in the right-side 
spectrum following the structural changes caused by the di-iodination of the triple bond. The 
doublet of doublets (H6b; appearing as a doublet in the figure due to scale) at 4.44 ppm and 
marked with a green arrow in the right side spectrum, has shifted from 4.27 ppm due to the 
structural changes caused by the di-iodination of the triple bond. The two unmarked multiplets 
appearing in both spectrums with virtually unchanged chemical shifts are associated with, from 
left to right, H4 and H2. 
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 Conclusions 
The experimental goal of this study was to optimize a radioiodination method that could be 
used to radiolabel sugar analogues for the purpose of studying plant carbohydrate metabolism 
by multimodality imaging. The radioiodination method described in this study is reasonably 
quick, one-pot reaction that leads to a selectively radioiodinated main product in a reasonably 
high yield, and it is likely that the method can be applied without significant modifications to 
radioiodinations of other, similar sugar analogues to the ones used in this study. Iodine has a 
variety of radioisotopes that suit many different imaging purposes and modalities, and, if the in 
vivo stability and behavior of compounds labeled with the method described in this study proves 
to be viable, radioiodination of sugar alkynyl derivatives could prove to be an effective and  
versatile method to produce suitable molecular tracers for plant carbohydrate metabolism 
studies. 
Optimization of the radioiodination method was concluded with satisfactory results, and the 
optimal carrier amount and reaction temperature for each tested solvent was fairly 
unambiguous. Selecting the optimal solvent, however, was not as straightforward. In 70 and 95 
°C, the highest RCY of main product [125I]3 and total yield of radioiodinated products were 
achieved with 2-propanol, but in 120 °C 2-propanol evaporated completely. In 95 °C slight 
evaporation of 2-propanol could be observed, but the use of Safe-Lock Eppendorf tubes 
prevented further evaporation. In 120 °C, RCY of [125I]3 surpassing those of 2-propanol in 95 
°C was achieved in cyclohexanol: however, no further tests were conducted in this temperature 
due to the safety risk the Eppendorf tubes’ heat tolerance (up to 100 °C) posed. The option to 
increase reaction temperature further was evaluated to be more crucial than the radiochemical 
yield under prevailing conditions: thus, cyclohexanol was selected as the solvent due to its 
significantly higher boiling point compared to 2-propanol. Initially, in 95 °C and with 3.0 µmol 
of carrier, total yields of radiochemical products differed notably between samples prepared in 
cyclohexanol and 2-propanol (40.60 % and 57.30 %, respectively; not statistically significant, 
however). Further experiments with cyclohexanol in 95 °C and with 3.0 µmol of carrier resulted 
in a statistically significant increase in total yield of radiochemical products, up to 77 %. The 
reason for the increase was not studied, but since the increase manifested consistently 
throughout the sample sets, it was concluded that cyclohexanol is the most optimal solvent of 
the ones tested.  
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Assuming a (plausible) 65 % RCY of [125I]3 has been achieved with 0.5 MBq of 125I by utilizing 
the Dowex®-mediated reaction studied in this work, and that 3 µmol of carrier I- reacts 
producing non-radioactive 3 in the same proportion, the molar activity of [125I]3 produced in 
this study is 0.1667 MBq/µmol. This molar activity is very low, and not suitable for in vivo 
purposes. However, since two iodine atoms are incorporated into the molecule when 3 is 
produced, the theoretical, carrier-free maximum molar activity of [125I]3 is 162,7 GBq/µmol, 
which is far more viable for in vivo purposes, since high molar activity radiotracers are typically 
to be in the order of 1011 Bq/µmol.93 125I is, though, unsuitable for in vivo studies due to its 
decay properties (and achieving the theoretical maximum molar activity is unlikely anyway), 
123I and 124I being more suitable radioisotopes of iodine for in vivo radiotracer. Theoretical, 
carrier-free maximum molar activities of [123I]3 and [124I]3 are 17.57 TBq/µmol and 2.312 
TBq/µmol, respectively. It is unlikely that these theoretical maxima can be actually achieved, 
but it is, however, plausible, that radiotracers of sufficient molar activity may be produced with 
the radioiodination method described in this study. 
The comparison to electrophilic substitution reactions indicated that, under the optimized 
conditions, the Dowex®-mediated reaction leads to superior yields compared to chloramine- 
and Iodogen-mediated reactions. However, the substrate and optimized reaction conditions 
differ significantly from those in which chloramine or Iodogen are typically applied. 
Chloramine T is typically used in radioiodinations of aromatic compounds94; peptides and 
proteins have been labelled with Chloramine, but the risk of oxidative damage to the substrate 
renders this an unfavourable method95,96. Chloramines have been applied in iodinations of 
terminal alkynes, and reaction yields up to 93 % were obtained with 4-phenyl-1-butyne as the 
substrate and Chloramine B as the oxidant, with significantly differing reaction conditions 
compared to those in this study: reaction was executed in room temperature, reaction time was 
two hours, the solvent used was ACN, and an excess of KI, compared to the substrate, was used 
as the source of I-.97 It seems unlikely, though, that this approach would work in 
radioiodinations without other adaptations than the addition of radioactive I-, since an excess of 
non-radioactive I- carrier will likely compete with radioactive I- during the reaction, leading to 
low radiochemical yield and molar activity. Iodogen is a mild oxidizing agent that is used in 
iodinations of proteins, peptides and other biomolecules that are sensitive to stronger 
oxidants94,98,99. It is typically used in aqueous buffer solutions, and the reactions are carried out 
in room temperature during relatively short (2 – 30 min) reaction times.94,98 As with Chloramine 
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T, the typical conditions for Iodogen reactions differ significantly from those used in this study, 
but the exact reason for the low yield remains elusive. However, in the optimized reaction 
conditions of this study it was remarkably obvious that the Dowex®-mediated reaction leads to 
the highest yields. 
The optimized radioiodination method was tested successfully on the sugar analogues. 
Radiochemical yields of the main products 6 and 7 were satisfactory (45 – 62 %), and it is likely 
that the yield may be further improved. The characterization confirmed that the reaction is 
regioselective towards the di-iodinated main product, as predicted by the results of the 
optimization phase; in addition, when using the glucose derivative 5 with two propargyl groups 
as possible reaction sites, the characterization indicated regioselectivity towards the propargyl 
moiety in 1-position over the moiety in 3-position, which could not be hypothesized from the 
optimization results. In addition to the main product peak, multiple radio peaks with shorter 
retention time were observed: these are suspected to be radioiodinated side products. However, 
these peaks manifested inconsistently throughout the sample batches and in such low yields 
(<10 %), that characterization of the side products was not considered relevant, or even feasible 
in the tested sample volumes. The shorter retention time compared to the main product indicates 
that the side products are structurally similar to the main product, except that one or more of 
their protective groups has disconnected during labeling. Disconnection of the protective 
groups was expected to occur during labeling: however, NMR characterization of the main 
products indicates that in the main product the protective groups remain intact. 
The exact reaction mechanism of the iodination method is not yet known, and the means to 
improve radiochemical yield likely depend on the mechanism. By increasing the reaction 
temperature, a higher radiochemical yield could possibly be achieved. Increasing the reaction 
temperature requires more heat-resistant sample vessels than used in this study, and in elevated 
temperatures iodine may escape the solution; however, the latter effect was not be observed in 
the temperatures used this study. Using a catalyst could possibly lead to improved 
radiochemical yield, in addition to providing more control over product selectivity100–102; 
however, using a catalyst may not be directly adaptable to the one-pot method used in this study, 
complicating the procedure, and the use of a heavy metal catalyst violates the green chemistry 
principle upon which the iodination method presented in this study is originally built90,91. In the 
tested scale the required amount of carrier NaI for one sample was of such a small mass that it 
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could not be accurately weighed: therefore, NaI was added as an aqueous solution, in addition 
to the 125I that was necessary to add in a solution. Removal of excess water had an observable 
(but statistically insignificant) effect on radiochemical yield, and by scaling up the synthesis 
the amount of water in a sample may be further reduced to improve yield. 
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Attachment 1. Radio-HPLC results of method optimization and comparison to electrophilic 
substitution 
Radio-HPLC results of method optimization and comparison to electrophilic substitution are 
presented in this attachment, combined to the sample batch parameters. 
Table 10. Radio-HPLC results of method optimization and comparison to electrophilic 
substitution. RCY (total and for individual products) is presented as a sample batch average. 
Standard deviation and error are calculated for total RCY, and are presented as absolute, not 
relative. 
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Attachment 2. Radio HPLC results of sugar analogue radioiodination 
Radio-HPLC results of sugar analogue radioiodination are presented in this attachment, 
combined to the sample batch parameters. 
Table 11. Radio-HPLC results of sugar analogue radioiodination. Standard deviation and error 
are calculated are presented as absolute, not relative. 
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Attachment 3. Results of statistical tests 
Results of statistical tests for this study are presented in this attachment. Degrees of freedom 
are calculated as n-1, where n = total sample size. Tests for statistical significance were tested 
with a two-tailed T-test assuming equal variances for two sample sets, and with a single-factor 
ANOVA for three sample sets. 
Table 12. Results of statistical tests.  
Test parameter Solvent Statistical test 
Degrees of 
freedom P-value 
Resin activation cyclohexanol T-test 4 0.307038 
Resin activation DMSO T-test 5 0.109828 
Resin activation 2-propanol T-test 4 0.544846 
Amount of carrier cyclohexanol ANOVA 8 0.035989 
Amount of carrier DMSO ANOVA 8 0.086890 
Amount of carrier 2-propanol ANOVA 8 0.438246 
Amount of carrier DMF ANOVA 7 0.510594 
Reaction temperature cyclohexanol ANOVA 8 0.026279 
Reaction temperature DMSO ANOVA 7 0.000649 
Reaction temperature 2-propanol T-test 5 0.569685 
Reaction temperature DMF ANOVA 8 0.010967 
Excess water removal cyclohexanol T-test 5 0.181704 
Comparison to electrophilic reactions cyclohexanol ANOVA 8 0.000001 
Radioiodination of sugar analogues cyclohexanol T-test 5 0.356533 
 
  
  
Attachment 4. NMR spectrum of 4 (1-(prop-2-yn-1-yloxy)-2,3,4,6-tetra-O-acetyl-D-glucose) 
  
  
Attachment 5. NMR spectrum of 5 (1,3-di-(prop-2-yn-1-yloxy)-2,4,6-tri-O-acetyl-D-glucose) 
  
  
Attachment 6. NMR spectrum of 6 (1-((E)-2,3-diiodo-prop-2-en-1-yloxy)-2,3,4,6-tetra-O-
acetyl-D-glucose) 
 
  
Attachment 7. NMR spectrum of 7 (1-((E)-2,3-diiodo-prop-2-en-1-yloxy)-3-(prop-2-yn-1-
yloxy)-2,4,6-tri-O-acetyl-D-glucose) 
 
